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Nitric  oxide  (NO)  is  a  gaseous  signalling  molecule  that  is  synthesised  by  nitric  oxide 
synthases (NOSs) and has a variety of physiological and pathophysiological roles.  Some of 
its  physiological  functions  are primarily  mediated  via the  activation  of soluble  guanylate 
cyclase.  However, NO is also able to potently inhibit mitochondrial respiration at complex 
IV of the electron transport chain (ETC) in a manner that is  reversible and in competition 
with  oxygen  (O2).  Following  prolonged  exposure  to  NO,  the  ETC  undergoes  an  NO- 
dependent modification at complex I, which results in a persistent inhibition of respiration.
Activated  macrophages  were  found  to  produce  NO,  via  upregulation  of the  inducible 
isoform of NOS  (iNOS),  in sufficient quantities to inhibit respiration.  This  inhibition was 
initially reversible but became persistent with time.  In addition, haem oxygenase-1  (HO-1) 
is  upregulated  in  these  cells,  producing  carbon  monoxide  (CO),  which  is  also  known  to 
inhibit complex IV.  The ability of exogenous and endogenous CO to inhibit respiration was 
investigated. Although less potent than NO, CO was shown to cause significant inhibition of 
respiration,  particularly  under  hypoxic  (1%  O2)  conditions.  Furthermore,  hypoxia  was 
found to attenuate significantly the synthesis of NO from iNOS but not CO from HO-1.
The consequences  of inhibition  of respiration  were  investigated under hypoxia,  where the 
availability  of O2  may  be  limiting  for  02-dependent cellular processes.  Specifically,  the 
effects of respiratory inhibition  were  investigated with regards to the stability of hypoxia- 
induced hypoxia inducible factor la (HIFla).  Hypoxia resulted in the stabilisation of HIFla 
protein, a phenomenon that was prevented by inhibition of the ETC at various complexes.
2This destabilisation of HIFla was found to be due to a redistribution of intracellular O2 from 
mitochondrial consumption, resulting in an increased intracellular O2 concentration and the 
reactivation of the 0 2 -dependent degradation of HIFla protein.
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TNFa Tumour necrosis factor a
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231   INTRODUCTION
241.1  Mitochondria
Mitochondria are small cellular organelles, typically 2pm in length and 0.5-1 pm in diameter. 
They are mobile and plastic structures with the ability to fuse with and separate from each 
other (Bossy-Wetzel et al.,  2003).  Their highly membranous  structure  is  related  to their 
primary  function,  which  is  to  synthesise  usable  energy  in  the  form  of  adenosine  5’- 
triphosphate (ATP; Brand etal., 2004).
The synthesis of ATP involves the electron transport chain (ETC) which resides in the inner 
mitochondrial membrane.  It is composed of a series of enzyme complexes that sequentially 
transport electrons, derived from respiratory substrates, coupling their passage through the 
chain with the pumping of protons from the mitochondrial matrix  into the intermembrane 
space.  The  localisation  of protons  in  the  intermembrane  space  creates  an  electrical  and 
chemical gradient across the mitochondrial membranes, and can be considered as a store of 
energy which  may be used to synthesise  ATP.  The  last of these enzymes is  complex IV 
(cytochrome  c  oxidase,  cytochrome  aa3).  It  passes  the  electrons  to  the  final  electron 
acceptor,  molecular  oxygen  (O2),  which  is  reduced  to  water.  It  is  this  reaction  that  is 
responsible  for  approximately  90%  of  a  cell’s  oxygen  consumption  (Brown,  1999; 
Piantadosi, 2002).
In addition to energy production, mitochondria have important roles in thermogenesis (Sell
et al., 2004) and apoptosis (Parone et al., 2002).  They may also be able to produce reactive
oxygen  species  (ROS)  which  have  been  proposed  to  be  involved  in  cellular  signalling
pathways  (Chandel  et al.,  2000b).  The  overproduction of ROS  by  mitochondria may  be
important  in  the  pathogenesis  of certain  diseases,  such  as  Parkinson’s  and  Alzheimer’s
25diseases and atherosclerosis.  Furthermore, mitochondria-derived ROS  may be involved in 
the process of cellular ageing (Brand etal., 2004).
1.1.1  Mitochondrial Structure
Mitochondria  possess  both  inner  and  outer  mitochondrial  membranes  (IMM  and  OMM 
respectively;  Figure  1).  The IMM is highly  convoluted,  forming structures  called  cristae. 
These provide a larger surface area to contain the components  of the ETC and associated 
proteins.  In addition, the EMM contains a high proportion of cardiolipin.  This phospholipid 
renders the IMM impermeable to solutes.  In contrast, the OMM is relatively permeable.  It 
contains many copies of the protein porin, which provides aqueous channels for solutes of 
up to 5kDa in size to pass through.
Between the IMM and OMM is the intermembrane space.  This region is acidic, containing 
a high concentration of protons.  This  localisation of protons creates both an electrical and 
chemical  gradient  across  the  mitochondrial  membranes.  The  steepness  of  this 
electrochemical  gradient  constitutes  the  mitochondrial  membrane  potential  (ATV 
approximately  150-T 80mV).  The higher the concentration of protons in the intermembrane 
space, the steeper the electrochemical gradient is, and the higher the A TV  The AT/m  has an 
important role  in  driving the synthesis  of ATP,  ROS  generation  (Brand et al.,  2004)  and 
apoptosis (Green & Kroemer, 1998).
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Figure 1.  The  structure  of a  mitochondrion.  The  folding  of the  inner  mitochondrial  membrane
(IMM) into the mitochondrial matrix forms structures called cristae.  Between the IMM and the outer 
mitochondrial membrane is the intermembrane space containing a high concentration of protons (TP).
Contained  within  the  IMM  is  the  mitochondrial  matrix  (Figure  1).  This  compartment 
contains  mitochondrial  DNA  and  many  enzymes,  including  those  involved  in  the  Krebs 
cycle.  It  is  from  the Krebs  cycle that most of the  electrons  are  obtained from  metabolic 
substrates and passed onto the ETC.  The carrier molecules that transport electrons are either 
pyridine nucleotides  (nicotinamide adenine dinucleotide; NAD+) or flavins  (flavin adenine 
dinucleotide; FAD).
1.1.2  The Electron Transport Chain
The  ETC  (Figure  2)  is  composed  of a  series  of enzyme  complexes:  complex  I  (NADH 
ubiquinone reductase; EC 1.6.5.3), complex II (succinate ubiquinone reductase; EC 1.3.5.1),
27complex III (ubiquinol cytochrome c reductase; EC 1.10.2.2) and complex IV (cytochrome c 
oxidase; EC 1.9.3.1).
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Figure 2.  The  mitochondrial  electron  transport  chain  (ETC).  The  ETC  consists  of a  series  of
enzyme complexes (I-IV) which sequentially transport electrons from reducing equivalents (NADH and 
FADH2) to the final electron acceptor 0 2, which is reduced to water.  As the electrons pass through the 
ETC,  their  transport  is  coupled  to  the  pumping  of protons  from  the  mitochondrial  matrix  into  the 
intermembrane space.  The flow of protons back into the mitochondrial matrix, through ATP synthase, 
releases free energy which is used to synthesise ATP from ADP.  The transport of electrons to complex 
III is performed by coenzyme Q (CoQ), and from complex III to complex IV by cytochrome c (cyt c).
1.1.2.1  Complex I
The majority of electrons that enter the ETC are passed onto complex I by reduced NAD+
(NADH).  Complex I is a large enzyme of approximately 850kDa and is composed of about
25  polypeptide  chains.  The  electrons  donated  by  NADH  are  accepted  by  the  flavin
mononucleotide  (FMN)  prosthetic  group  and  then  passed  onto  the  iron-sulphur  (Fe-S)
clusters, where the iron atoms are reduced into the ferrous state (Fe2+).  As the electrons pass
28through  the  complex,  their  transport  is  coupled  to  the  pumping  of  protons  from  the 
mitochondrial matrix into the intermembrane space.  Ubiquinone then receives the electrons 
from complex I, oxidising the Fe-S clusters back into the ferric state (Fe3+).
Ubiquinone, also called coenzyme Q (CoQ), is an electron carrier that transports electrons 
from  either  complex  I  or  II  to  complex  III.  It  is  a  small  molecule  containing  6  to  10 
hydrophobic  five-carbon  isoprene  units,  confining  it to  the IMM.  Upon  acceptance  of a 
single electron ubiquinone is reduced to ubisemiquinone.  By accepting one further electron 
it is fully reduced into ubiquinol.
1.1.2.2  Complex III
Complex ID contains two types of cytochromes:  cytochrome b and cytochrome ci.  These 
are  electron-transferring  proteins  that contain  a  haem  prosthetic  group.  In  contrast  with 
ubiquinone, cytochromes can only accept one electron which reduces the haem iron to Fe2+. 
Ubiquinol donates its two electrons to complex III via a two-step process.  The first electron 
is transferred to an Fe-S cluster, oxidising ubiquinol to ubisemiquinone.  Ubisemiquinone is 
then fully oxidised into ubiquinone by donation of its remaining electron to cytochrome b. 
This  electron  is  then  ‘recycled’  back  to  another  ubisemiquinone  molecule  to  reform 
ubiquinol.  This recycling process is called the Q cycle.  Upon acceptance of an electron the 
Fe-S cluster of complex III passes it onto cytochrome C i which then reduces cytochrome c.
Cytochrome c is another electron carrier.  It is loosely bound onto the outer surface of the 
IMM and shuttles electrons from complex m to complex IV.
291.1.2.3  Complex IV
Complex  IV  is  the  terminal  enzyme  of the  ETC  and  passes  the  electrons  to  the  final 
acceptor, O2.  It contains two cytochromes, cytochromes a and a3, and two copper centres, 
copper a (Cua) and copper b (Cub).  Cytochrome a and Cua are paired together on the same 
subunit and are the initial acceptors of the electrons from cytochrome c.  The electrons are 
then transferred to the binuclear centre composed of haem a3 and Cub located in subunit I of 
complex IV.  The haem  is  reduced  to Fe2+  and the  Cub  centre  is  reduced to the cuprous 
(Cu+) form.  In this  reduced state the binuclear centre donates these electrons, along with 
four protons, to O2, reducing it into water.
1.1.2.4  ATP Synthesis
As  the electrons  pass  through  the  ETC,  and protons  are pumped  into  the  intermembrane 
space, the electrochemical gradient, which constitutes the proton motive force and the ATV 
is formed.  This gradient can be considered as a store of free energy that may be used to 
drive chemical reactions.  In this case the release of free energy is used to drive the synthesis 
of ATP (Hinkle and McCarty, 1978).  ATP synthase is an enzyme that is also located in the 
IMM.  It  provides  a  pore  through  which  protons  can  flow  down  their  electrochemical 
gradients  from  the  intermembrane  space  back  into  the  mitochondrial  matrix.  When  this 
occurs, the free energy that is released  is  coupled to the phosphorylation of adenosine  5’- 
diphosphate (ADP) to form ATP.  This chemiosmotic coupling forms an essential part of the 
conversion of energy derived from metabolic substrates into a form that is usable by the cell, 
a process called oxidative phosphorylation (Mitchell, 1961).
301.1.2.5  Complex II
Complex II is also part of the ETC.  However, unlike the other complexes, it does not pump 
protons  into the intermembrane space.  It receives  electrons  from  reduced FAD (FADH2) 
that is also produced from the Krebs cycle and passes them initially to its Fe-S clusters, and 
then onto the ubiquinone pool.
1.1.3  Other Functions of the Mitochondria
In  addition  to  ATP  synthesis,  mitochondria  are  also  involved  in  other  cellular  processes 
including thermoregulation (Sell etal., 2004) and apoptosis (Parone etal., 2002; Green and 
Kroemer, 1998).
1.1.3.1  Mitochondria and Thermogenesis
Thermogenesis  is the production of heat.  It increases  in cold climates and is an  important 
adaptive response.  One of the mechanisms by which thermogenesis may occur is through 
dissipation  of the  free  energy  that  is  stored  by  the  proton  electrochemical  gradient  in 
mitochondria.
Brown adipocytes are lipid storage cells characterised by numerous mitochondria containing 
many cristae.  They are located in brown adipose tissue (BAT) which is often found in small 
and newborn mammals.  The function of brown adipocytes is to generate heat.  During cold 
acclimatisation,  BAT  is  stimulated  by  the  sympathetic  nervous  system  resulting  in  the 
upregulation and activation of uncoupling protein 1   (UCP1; Ricquier etal.,  1983).  UCP1  is 
located on the IMM and allows the passage of protons from the intermembrane space into
31the mitochondrial  matrix.  Since UCP1  provides an  alternative path for the protons  to re­
enter the mitochondrial matrix, it uncouples the oxidation of respiratory substrates from the 
synthesis  of ATP  via  ATP  synthase.  The  free  energy  that  is  released  from  the  protons 
passing through UCP1 is dissipated as heat (Sell etal., 2004).
1.1.3.2  Mitochondrial Role in Apoptosis
Apoptosis is a form of cell death that has been shown to be important in the development 
and tissue homeostasis of multicellular organisms.  It involves the activation of caspases, a 
family  of  cysteinyl  proteases,  which  may  occur  via  a  mitochondrial-dependent  or  - 
independent pathway.
Mitochondria  contain  a  number  of  proapoptotic  agents,  including  cytochrome  c, 
smac/diablo, apoptosis-inducing factor and endonuclease G, and the release of these agents 
into  the  cytosol  promotes  apoptosis.  For  example,  the  apoptosome  is  formed  when 
cytochrome c is released, which is then able to activate caspases-3 and -9.  Evidence exists 
that suggests that the release of cytochrome c and other proapoptotic agents is regulated by 
the Bcl-2 family of proteins acting at the mitochondria.
The Bcl-2 proteins contain a number of homology domains (BH-1, -2, -3 and -4) and can be 
divided into two groups; those that are antiapoptotic (e.g. Bcl-2 and B c1-Xl) and those that 
are  proapoptotic  (e.g.  Bax  and  Bak).  It  has  been  suggested  that  the  proapoptotic  Bcl-2 
proteins are able to form channels within the mitochondrial membranes to allow the passage 
and release of cytochrome c.  The antiapoptotic Bcl-2 proteins, however, are able to prevent 
the formation of these channels.
32Thus, regulation of the release of proapoptotic agents from the mitochondria by the Bcl-2 
family of proteins may promote or prevent apoptosis.
1.1.4  Mitochondrial Generation of Reactive Oxygen Species
Mitochondria have also been implicated in a number of signal transduction pathways.  These 
pathways include the activation of nuclear factor kappa-B (NF-kB; Palacios-Callender et al., 
2004; Zhang & Chen, 2004), stabilisation of hypoxia-inducible factor-1 a (HIFla;  Chandel 
et ah, 2000) and the activation of c-Jun NH2-terminal kinase (JNK; Zhang and Chen, 2004). 
Mitochondria  have  been  proposed  to  modulate these  pathways  through  the  generation  of 
ROS.
At certain points in the ETC, the electrons that are being transported may be passed onto O2 
to  produce  superoxide  anion  (02*).  In  fact,  it  has  been  suggested  that  1-3%  of the  O2 
consumed by mitochondria may be converted into O2’ by the ETC (Carreras et al., 2004). 
This free radical is very reactive and unstable, with a half-life (ti/2) of about a microsecond, 
and may react with and damage proteins, DNA and lipids.  In addition to O2', ROS includes 
hydrogen peroxide (H2O2) and hydroxyl radicals.  O2’ can be metabolised by enzymes called 
superoxide dismutases (SOD) to produce H2O2, which is less reactive but has a longer ti/2. 
There  are  two  types  of SOD:  MnSOD,  which  is  found  in  the  mitochondrial  matrix,  and 
Cu/ZnSOD,  which  is  found  in  the  cytosol.  H2O2  itself can  be  converted  into  hydroxyl 
radicals in the presence of ferrous iron via the Fenton reactions.
33The production of O2’ is correlated with the AT^, with a high  favouring the production 
of 02* (Brand et al.,2004).  Once produced, O2' may be directed into the cellular cytosol or 
into  the  mitochondrial  matrix.  Various  antioxidant  defense  mechanisms,  such  as 
glutathione, SOD (Raha etal., 2000), thioredoxin (Winyard etal., 2005) and catalase (Radi 
et al.,  1991),  may  scavenge  or  metabolise  the  ROS,  thus  preventing  the  possibility  of 
cellular damage caused by these reactive species.
Conditions which cause the components of the ETC to be in a more reduced state may also 
increase the likelihood of ROS generation by the mitochondria.  Such situations may arise 
when  downstream  complexes  (e.g.  complex  IV)  become  inhibited,  such  as  in  hypoxia 
(Duranteau et al.,  1998;  Palacios-Callender et al.,  2004).  The  effect of this  would  be to 
decrease  the  rate  of electron  transport through  the  chain  and  to  increase  the  risk  of the 
electrons ‘leaking’ to O2.
1.1.4.1  Mitochondrial Sites of ROS Production
The  precise  locations  of  ROS  generation  in  the  ETC  are  still  unclear.  However, 
accumulating  evidence,  much  of it  based  on  in  vitro  experiments  using  either  isolated 
mitochondria or submitochondrial  particles, suggests that both  complex I and complex III 
may be sites of significant ROS production.
1.1.4.1.1 Production of ROS at Complex I
Complex I has  been  suggested to  be  a major site of O2’ production  (Brand et al.,  2004). 
ROS can be detected in submitochondrial particles (Turrens and Boveris, 1980) inhibited by
34rotenone,  an inhibitor of complex I near the ubiquinone binding  site  (Okun  et al.,  1999). 
However,  in  intact  mitochondria  rotenone  does  not  generate  detectable  ROS  production 
(Chen  et al.,  2003).  It  has  been  suggested  that  02*  is  released  by  rotenone-inhibited 
mitochondria  into  the  matrix  side  where  it  is  dealt  with  by  antioxidant  mechanisms 
(Grigorieff, 1999).  Since O2’ cannot traverse lipid membranes, it is effectively localised and 
eliminated in this compartment.  In submitochondrial particles, however, it has been shown 
that  antioxidant  mechanisms  are  depleted  and  the  mitochondrial  membranes  may  be 
inverted; such conditions permit ROS to be detected.  This could explain the contradictory 
results observed by Chen etal. and Turrens and Boveris.
From  these  observations  it has  been  inferred  that  in  cells  with  intact  mitochondria,  ROS 
produced by complex I are eliminated within the matrix.  As a result, any effects exerted by 
the  ROS  are  confined  to  the  inside  of  the  mitochondrion  and  subsequently  have  no 
extramitochondrial actions.
1.1.4.1.2  Generation of ROS at Complex III
Complex  ID  may  also  be  a  site  of significant  ROS  generation  (St-Pierre  et al.,  2002). 
Inhibitors  (e.g.  antimycin  a)  that  block the  distal  end  (Qj  centre)  of complex  HI  prevent 
electron donation to cytochrome c but not electron acceptance from ubiquinol, resulting in 
the  production  of detectable  ROS  (St-Pierre  et al.,2002;  Chen  et al.,  2003).  However, 
myxothiazol, which inhibits the proximal end (Q0 centre) of complex DI and thus prevents 
electron acceptance from ubiquinol, does not result in detectable ROS production in intact 
isolated mitochondria.
35Since the ROS  produced from complex ID has  been  detected  extramitochondrially,  it has 
been  suggested  that ROS  produced  from  this  site  may  be  involved  in  cellular  signalling 
transduction mechanisms (Chandel etal., 2000b).
361.2  Nitric Oxide
Nitric oxide (NO) is a gaseous free radical molecule that is produced enzymatically within 
cells.  It is both water and lipid soluble (approximately 8 times more soluble in membranes; 
from Shiva et al., 2001) and, as with O2" , has a short ti/2 (seconds; Moncada et al.,  1991). 
Nevertheless, NO has been shown to be capable of traversing biological membranes to exert 
effects in neighbouring cells (Brown etal., 1998).
Since its initial identification as an endogenous vasodilator molecule (Palmer et al.,  1987), 
NO  has  been  shown  to  play  important  roles  in  the  cardiovascular,  nervous  and  immune 
systems (Moncada et al.,  1991).  Most of the physiological effects of NO are mediated by 
activation  of its  receptor soluble  guanylate  cyclase  (sGC;  Bellamy  &  Garthwaite,  2002). 
More recently, however, NO has been demonstrated to interact with complex IV of the ETC 
in a reversible manner (Brown & Cooper, 1994; Cleeter et al., 1994; Schweizer and Richter, 
1994).  Furthermore,  NO  may react with,  and  persistently  inhibit,  complex I  of the ETC 
(Beltran et al.,  2000).  These  interactions  may  have  both  physiological  (Clementi  et al.,
1999)  and pathophysiological (Bolanos etal., 1994) consequences for the cell.
1.2.1  Nitric Oxide Biosynthesis
Nitric oxide is produced endogenously by a group of enzymes called nitric oxide synthases 
(NOSs; Figure 3).  There are currently three established isoforms of this enzyme: neuronal 
NOS  (nNOS,  type  I  NOS),  inducible  NOS  (iNOS,  type  II  NOS)  and  endothelial  NOS 
(eNOS, type HI NOS), each of which are products of separate genes (Alderton etal., 2001).
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Figure 3.  The  substrates,  cofactors  and  products  of  nitric  oxide  synthase  (NOS).  NOSs  use
NADPH, L-arginine and 0 2 as substrates to produce NADP, citrulline and NO.  In addition, the enzyme 
requires the presence of a number of cofactors including flavin mononucleotide (FMN), flavin  adenine 
dinucleotide (FAD), tetrahydrobiopterin (BH4) and calcium-calmodulin (CaM).
Nitric oxide synthases  use a number of common substrates  and  cofactors  to produce NO. 
The amino  acid L-arginine, NADPH and O2 are the substrates for NO synthesis,  with the 
nitrogen atom derived from the guanidino nitrogen of L-arginine (Palmer et al., 1988).  The 
enzymes  catalyse  the  sequential  oxidation  of  L-arginine,  using  electrons  donated  by 
NADPH, to produce stoichiometric quantities of NO and citrulline (Bush et al.,  1992), via a 
transient intermediate, N™-hydroxy-L-arginine (Stuehr etal., 1991).
A  number  of cofactors  are  necessary  for  NOS  activity.  These  cofactors  are  generally 
involved in transferring electrons from NADPH to the substrates (FMN, FAD), or they are 
involved with the formation of the active enzyme (tetrahydrobiopterin, calmodulin).
381.2.1.1  General Structures of Nitric Oxide Synthases
Each  monomeric  polypeptide  of  NOS  consists  of a  reductase  and  oxygenase  domain, 
separated by a calmodulin (CaM)-binding region.  Each of these domains has functions that 
contribute to the overall catalytic reaction performed by NOS.
1.2.1.1.1 The Oxygenase Domain
The oxygenase domain of NOS contains the active site of the enzyme.  It is located on the 
amino-terminal  end  of  the  polypeptide  and  contains  the  binding  regions  for  haem, 
tetrahydrobiopterin  (BH4)  and  L-arginine,  which  are  required  for  the  functional  enzyme. 
Only  the  oxygenase  domain  is  apparently  involved  in  the  formation  of  the  active 
homodimeric enzyme (Ghosh etal.,  1997).  In addition, this region contains binding motifs 
for caveolins which may be involved in the localisation of NOS to membranes.
1.2.1.1.2 The Reductase Domain
The reductase domain of NOS is situated at the carboxy-terminal of the polypeptide chain. 
It bears  a  remarkable  homology  with  the  cytochrome  P450-reductase  family  of enzymes 
(approximately 50%; Wang etal., 1997) and, like these enzymes, its principal function is to 
transport electrons from NADPH to the substrates  located in the oxygenase domain.  The 
electron  carriers  involved  in  NOS  include FMN and FAD.  In  fact,  the rate at which the 
active enzyme synthesises NO depends upon the rate at which electrons can be shuttled to 
the oxygenase domain.  This  was  shown through the use of chimeric enzymes  containing 
combinations  of  the  oxygenase  and  reductase  domains  from  different  NOS  isoforms 
(Nishida et al., 1998).
391.2.1.1.3  The Calmodulin Binding Region
Separating the oxygenase and reductase domains of NOS is an approximately 30 amino acid 
sequence  which  forms  the  binding  region  for the  cofactor  CaM.  Calmodulin  is  able  to 
incorporate itself into NOS when it is activated by bound calcium.  Calmodulin binding to 
the enzyme triggers the flow of electrons from the reductase to the oxygenase domains and 
thus  synthesis  of NO  (Abu-Soud  et al.,  1994).  Thus,  calcium  may  also  be  a  necessary 
requirement for NOS activity (Moncada et al., 1991).
1.2.1.2  Nitric Oxide Synthase Isoforms
The three established isoforms of NOS may be described as either constitutive (eNOS and 
nNOS)  or  inducible  (iNOS).  Constitutively  expressed  NOS  enzymes  are  principally 
involved  with  the  physiological  actions  of  NO,  including  neurotransmission  and 
vasorelaxation (Moncada et al.,  1991).  They produce NO in picomolar quantities and their 
activites  are  transient,  regulated  by  increased  intracellular  calcium  concentrations  and 
activation  of  CaM  (Bredt  &  Snyder,  1994).  Inducible  NOS  is  mainly  involved  in 
immunological  responses.  It is  not normally expressed and  is  induced  in certain cells by 
particular stimuli.  This  isoform has  activity that is  CaM-independent,  already  containing 
activated CaM that is tightly bound, and therefore, once expressed, produces NO constantly 
in  micromolar  concentrations.  As  a  result  of its  high  NO  generation,  iNOS  has  been 
associated with the pathophysiological effects of NO.
401.2.1.2.1 Endothelial NOS
Endothelial  NOS  was  named  according to  the cell  in  which  it was  originally  discovered. 
However, eNOS is also present in non-endothelial cells including platelets (Radomski et al., 
1990) and some neurones (Dinerman et al.,  1994).  It is a 133kDa protein and is one of the 
constitutive  NOS  enzymes.  Unlike  the  other NOS  isoforms  it  is  normally  found  in  the 
particulate  fraction  of  a  cell.  It  has  been  shown  that  eNOS  can  be  localised  onto 
membranous structures, particularly to the caveolae (Shaul etal., 1996; Michel etal., 1997). 
These  are  microdomains  of the  plasma  membrane  that  contain  caveolins,  the  protein  to 
which  eNOS  may  be  bound.  Recently,  it  has  been  shown  that  eNOS  may  also  be 
sublocalised onto mitochondria via a pentabasic amino acid sequence (Gao et al., 2004).
In addition to CaM regulation, eNOS can also be activated by phosphorylation (Dimmeler et 
al.,  1999).  Endothelial cells experience shear stress from the drag exerted by the flow of 
blood  in  vessel  lumen.  This  force  can  activate  the  phosphatidylinositol-3-OH  kinase 
(PI3K)/Akt pathway.  The  subsequent activation  of the  Ser/Thr kinase  Akt results  in  the 
phosphorylation of eNOS on Ser1177 resulting in its activation.  In this activated state, eNOS 
shows activity that is CaM-independent (Dimmeler et al., 1999).
1.2.1.2.2 Neuronal NOS
As with eNOS, nNOS is also a constitutive NOS isoform.  It is a larger protein of 161kDa in 
size  and  is  found  mainly  in  the  brain  and  nitrergic  neurones  of the  peripheral  nervous 
system.  It is a soluble enzyme that is located in the cytosol.
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the postsynaptic neurone.  Once ligated, the NMDA receptor opens an ion channel to allow 
the  influx  of calcium  into  the cell.  This  calcium  can  then  activate  CaM,  which  in  turn 
stimulates nNOS  activity.  Like eNOS,  nNOS can also be phosphorylated (Hayashi et al.,
2000).  This reaction is catalysed by CaM-dependent protein kinases  and targets  Ser847 of 
nNOS.  In contrast with eNOS, however, this phosphorylation event results in a decrease in 
nNOS activity (Hayashi etal., 2000).
1.2.1.2.3  Inducible NOS
Inducible NOS  is unlike the other NOS  isoforms in that it is not constitutive and produces 
significantly greater  quantities  of NO.  It  too  is  a  soluble  enzyme  that  is  located  in  the 
cytosol  and  is  a  protein  of  131kDa  in  size.  It  was  originally  identified  in  activated 
macrophages that displayed anti-tumour activity, a property which is attributed in part to its 
production of NO.  However, the large quantites of NO produced by iNOS have also been 
associated  with  pathological  conditions  such  as  septic  shock,  arthritis  and  inflammatory 
bowel syndrome.
As  active  iNOS  already  binds  CaM  tightly,  the  enzyme  is  insensitive  to  changes  in
intracellular  calcium  concentrations.  Its  activity  is  therefore  regulated  by  other  means,
principally by expression at the mRNA level.  Inducible NOS expression  is  stimulated by
bacterial endotoxin (lipopolysaccharide; LPS) as well as by a number of pro-inflammatory
cytokines including tumour necrosis factor-a (TNFa), interferon-y (IFNy) and interleukin-1
(IL-1).  In  addition,  its  expression  may  also  be  inhibited  by  certain  cytokines  such  as
interleukin-4, -8 and -10 (McCall et al.,  1992).  The induction of iNOS expression leads to
42an increase in iNOS mRNA whose levels may be modulated.  Post-transcriptional regulation 
of the  iNOS  mRNA has  been  reported to  be  modulated  by transforming  growth  factor-(3  
(TGFp; Vodovotz etal.,  1994) which destabilises the mRNA.  In addition, NO itself has also 
been  shown  to  reduce  the  mRNA  levels  of iNOS.  The  inhibition  of NOS  activity  in 
activated macrophages causes iNOS mRNA levels to increase, whereas treatment with NO 
from an NO donor dose-dependently reduces iNOS mRNA levels (Hinz et al., 2000).  Nitric 
oxide  has  also  been  shown  to  inhibit  iNOS  protein  activity  (Assreuy  et al.,  1993)  by 
targeting the haem group in the enzyme.  This effect is reversible and has been proposed to 
be  a feed-back  mechanism to  prevent excessive NO  production.  Inducible  NOS  protein 
activity may also be inhibited by the lack of availability of substrates, such as L-arginine, or 
of cofactors, such as BH4 (Mori and Gotoh, 2000).
1.2.1.2.4  Mitochondrial NOS
In addition to the three distinct isoforms of NOS described above, there may exist a fourth 
mitochondrial isozyme.  This mitochondrial NOS (mtNOS) has been shown to produce NO 
in sufficient quantities to inhibit respiration in isolated mitochondria, particularly upon the 
addition of exogenous L-arginine (Giulivi,  1998).  This inhibition can be prevented by the 
inhibitor  of NOS,  NT-monomethyl-L-arginine  (L-NMMA),  or  by  oxyhaemoglobin  which 
binds NO.
However, the exact identity of mtNOS remains unclear.  Previous reports have shown that 
the  isozyme  exhibits  Ca2+-dependent  activity,  similar  to  that  of  the  constitutive  NOS 
enzymes (Ghafourifar and Richter,  1997).  However, it has also been described to be similar
43to iNOS, based on characteristics such as reactivity to monoclonal antibodies and molecular 
weight (Tatoyan and Giulivi, 1998).
Evidence demonstrating that mtNOS is either nNOS or eNOS has been provided by several 
studies.  Cardiomyocytes  obtained  from  nNOS  knockout (KO)  mice have been  shown  to 
lack mitochondrial NO production compared with the wild-type (WT; Kanai et al.,  2001). 
In addition, nNOS has been identified in only 13% of neuronal mitochondria obtained from 
nNOS  KO mice,  compared with  85%  in the WT  (Rothe et al.,  1999).  These  reports  are 
consistent with the proposal that mtNOS is nNOS.  In contrast,  myocardial tissue obtained 
from  eNOS  KO  mice  does  not demonstrate  an  inhibition  of respiration  upon  stimulation 
with bradykinin (Loke etal., 1999).  This suggests that mtNOS may be eNOS.
Therefore it remains to be established whether or not a specific mtNOS exists or whether the 
NOS sited in the mitochondria is actually a previously-described isoform.
1.2.2  Targets of Nitric Oxide
Nitric oxide is able to bind to haem groups and to modulate the activities of the enzymes that 
contain  them.  The  most  established  target  for NO  is  sGC.  In  the  last  decade  another 
biological  target  has  risen  to  prominence.  It too  is  a  haemoprotein  and  is  the  terminal 
enzyme of the ETC, complex IV.
441.2.2.1  Soluble Guanylate Cyclase
Soluble guanylate cyclase is a heterodimeric protein that is composed of a and (3  subunits.  It 
is the main target through which NO  exerts  its physiological  actions.  It contains  a haem 
group to which NO binds and activates the enzyme (ED50 = ~20nM; Bellamy et al., 2000). 
Once bound, NO  induces a conformational change in the enzyme resulting in an increased 
activity  of several  hundred  fold.  The  enzyme  catalyses  the  conversion  of guanosine  5’- 
triphosphate  (GTP)  into  cyclic  guanosine  3’,5’-monophosphate  (cGMP),  which  acts  as  a 
second messenger for signal transduction.  Cyclic GMP has three principal targets: cGMP- 
dependent protein  kinases  (Lohmann  et al.,  1997),  cGMP-gated  cation  channels  (Zagotta 
and  Siegelbaum,  1996)  and cGMP-regulated  phosphodiesterases  (Degerman et al,  1997). 
Through these mechanisms NO exerts  its physiological actions  including the regulation of 
vascular tone (Warner et al.,  1994), the regulation of platelet aggregation (Buechler et al., 
1994) and neurotransmission (Jaffrey & Snyder, 1995).
1.2.2.2  The Electron Transport Chain
Complex  IV  of the  ETC  has  also  been  shown  to  be  a  target of NO,  which  inhibits  the 
enzyme in a manner that is reversible and competitive with O2 (Brown and Cooper,  1994; 
Cleeter et al.,  1994; Schweizer and Richter,  1994).  The site that NO and O2 compete for is 
the binuclear centre of the enzyme, consisting of a haem (haem a3) and copper (Cub).  Both 
NO and O2 have similar rates of association with the fully-reduced (Fe2+-CuB+) enzyme (k = 
0.4-1.0x1 (^NrV1   and  ^M ^s'1   respectively;  Blackmore  et  al.,  1991;  Babcock  and 
Wikstrom,  1992).  However,  NO  has  been  shown  to  inhibit  complex  IV  rapidly 
(milliseconds to seconds) and potently, even when the concentration of O2 is 40 to 500 times 
greater than that of NO.
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concentration of O2, the IC50 of NO is 270nM.  Between  18-38pM O2, approximately the 
tissue  O2  concentration,  the  IC50  is  60nM  NO  (Brown  and  Cooper,  1994).  Others  have 
reported similar IC50 values (364nM NO between  140-190pM O2, 41nM at 50pM O2) and 
have calculated the Ki for NO acting at complex IV to be 27nM (Koivisto etal., 1997).  The 
explanation for the greater potency of NO binding to complex IV compared to O2 appears to 
be that NO can bind onto the enzyme when it is partially (Fe2+-Cus2+ or Fe3+-CuB+) or fully-
24”  4”  * reduced (Fe  -Cub  ), whereas O2 can only bind to the latter form (Babcock and Wikstrom, 
1992).
The exact mechanism by which NO binds to  complex IV remains to be clarified but two 
main hypotheses have been suggested.  The first proposes that NO binds onto the Fe2+ of the 
partially-reduced enzyme and prevents the interaction of complex IV with O2 (Giuffre et al., 
1996).  The second hypothesis claims that NO initially binds onto Cub  (Cu+ or Cu2+) of the 
partially-reduced  enzyme,  which  then  prevents  O2  from  interacting  with  the  haem  iron 
(Torres et al.,  1995).  This second hypothesis also suggests that the interaction of NO with 
the Cub  leads to the hydration and metabolism of the gas to form nitrite (NO2 ) within the 
binuclear  centre.  The  NO2',  when  formed,  inhibits  complex  IV  effectively  because  it 
diffuses out of the binuclear centre slowly (Torres etal., 1998).
In addition to the reversible inhibition at complex IV, NO, or one of its related species, has 
been reported to  inhibit the activity of the ETC persistently or irreversibly.  Cells (Jurkat, 
L929 and J774) treated with (Z)-l-[2-aminoethyl-N-(2-ammonioethyl)amino] diazen-l-ium-1,2-diolate  (DETA),  which  releases  a  constant  amount  of  NO  over  the  course  of the 
experiment, for prolonged periods resulted in the persistent inhibition of respiration that was 
attributed to S-nitrosylation of complex I (Clementi etal.,  1998; Beltran etal., 2000; Orsi et 
al.,  2000).  In  these  studies,  respiration  occurring  through  complexes  I,  III  and  IV  was 
inhibited  whereas  respiration  through  complexes  II,  III  and  IV  was  unchanged  after 
exposure to  1.5pM NO.  Furthermore, nitration of complex I was  discounted because the 
persistent inhibition was  reversed by the addition of reduced glutathione ethyl-ester or by 
cold  light,  properties  that  are  exhibited  by  S-nitrosylation.  In  addition,  the  ONOO- 
scavenger  and  the  SOD  mimetic  MnTBAP  did  not  prevent  the  inhibition  of complex  I, 
suggesting that ONOO- was not the nitrosylating species (Clementi etal., 1998).  It was also 
reported that S-nitrosylation of complex I only occurred after the intracellular concentrations 
of reduced glutathione had fallen.  This was supported by the acceleration of the persistent 
inhibition upon treatment of the cells with the glutathione synthesis  inhibitor L-buthionine 
(S,  R)-sulphoximine.  Thus,  the  persistent  inhibition  of NO  on  mitochondrial  respiration 
may only occur when the redox state of the mitochondrion has been compromised.
In contrast, direct treatment of isolated mitochondria with peroxynitrite (ONOO ), which can 
be produced intracellularly by the reaction between NO and O2’ (Radi et al., 1994; Murray et 
al.,  2003),  resulted  in  the  inhibition  of complexes  I,  II and IV.  This  effect could  not be 
reversed by the antioxidant dithiothreitol, ruling out inhibition by S-nitrosylation, and was 
suggested to be due to nitration of the enzyme complexes by ONOO’ (Murray et al., 2003). 
Previous  work has also been carried out using NO donors that is  in agreement with these 
observations (Riobo et al., 2001).  The inhibition of respiration by NO acting at complex IV 
was  proposed to  increase the formation  of O2'  from the  mitochondria,  which  would then
47react  with  NO  to  produce  ONOO'.  This  ONOO'  could  then  react  with  and  nitrate 
components of the ETC.  An  inhibition of complex I was observed that was prevented by 
SOD.  This  implicates  ONOO' as the species  involved  in causing the effect.  In  contrast, 
however, no effects on complex II or El were observed  in this study.  Experiments using 
activated astrocytes have also provided evidence for ONOO’ causing irreversible inhibition 
of the ETC  (Bolanos et ah,  1994).  Astrocytes  activated with LPS and EFNy  exhibited an 
irreversible inhibition of complex IV that was prevented by SOD and catalase.  No effects 
on complex I, however, were observed.
Recently, it has been reported that both S-nitrosylation and nitration of complex I may occur 
in concert in activated macrophages (Frost et ah, 2005).  It was shown that an early NO- 
dependent  inhibition  of  complex  I  activity  could  be  prevented  by  addition  of  reduced 
glutathione ethyl-ester,  indicating S-nitrosylation.  The ability of glutathione ethyl-ester to 
prevent  this  inhibition  diminished  with  time  and  was  coupled  with  the  appearance  of 
nitrotyrosine residues.
A  variety  of  cell  types  have  been  exposed  to  NO,  whether  endogenous  or  exogenous 
(Bolanos  et al.,  1996;  Clementi  et ah,  1998;  Beltran  et ah,  2000).  Similar  effects  upon 
mitochondrial  respiratory  activity  were  observed  and  a  decrease  in  intracellular  GSH 
concentration  was  implicated  as  a  contributor  to  loss  of  complex  I  activity.  This 
phenomenon  was  exemplified  by  the  increased  susceptibility  of astrocytes  to  ONOO-  
induced  complex I damage after GSH depletion (Barker et ah,  1996).  Astrocytes  have  a 
higher specific activity of y-glutamylcysteine synthetase, the rate-limiting enzyme of GSH 
synthesis,  than  neurons.  This  may  be  responsible for the  greater resistance  of astrocytes
48compared with neurons to ONOO' (Bolanos et al.,  1995).  Furthermore, it has been shown 
that the ability of astrocytes to upregulate glycolysis in response to respiratory inhibition by 
NO protects it from apoptosis, as is observed in neurons, which cannot upregulate glycolysis 
(Almeida et al., 2001).  Thus, the effects of NO upon cells may be dictated by a variety of 
factors,  such  as  the  intracellular  concentration  of  GSH  and  the  ability  to  upregulate 
apoptosis, which have been described here.
491.3  Carbon Monoxide
Carbon monoxide (CO), like NO and O2" , is a gaseous diatomic molecule that is produced 
endogenously by cells.  However, unlike NO and O2’, it is not a free radical and as a result is 
less reactive and more stable.  In fact, the only clearly established targets for CO are haem- 
containing  proteins.  Nevertheless,  CO  has  been  implicated  in  a  number  of biological 
functions,  such  as  neurotransmission,  vasorelaxation  and  inhibition  of  smooth  muscle 
proliferation  (Ryter  and  Otterbein,  2004).  It  is  produced  enzymatically  by  a  group  of 
enzymes  called haem oxygenases  (HO;  Tenhunen et al.,  1969; Maines,  1997),  consuming 
the substrates haem, NADPH and oxygen.
1.3.1  Carbon Monoxide Biosynthesis
Haem oxygenase enzymes catalyse the rate-limiting step in haem catabolism, a mechanism 
that is responsible for over 85% of endogenously produced CO.
The HO enzymes are normally colocalised with another enzyme, NADPH:cytochrome P450 
reductase, which provides the substrate NADPH as an electron donor.  The electrons derived 
from NADPH have two functions: to activate O2 and to reduce the haem iron to the ferrous 
state.  Haem and O2 are required for HO activity, which produces equimolar quantities of 
free  divalent iron  (Fe2+),  CO and  linear tetrapyrrole biliverdin.  Biliverdin  is  then  rapidly 
converted into bilirubin by the enzyme biliverdin reductase (Tenhunen etal., 1970).
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molecule.  It  is  released  by  the  oxidation  of this  atom  by  O2  in  an  NADPH-dependent 
reaction.
Three isoforms of the HO enzyme have been identified: HO-1, HO-2 and HO-3.
1.3.1.1  Haem Oxygenase-1
Haem oxygenase-1 is the most widely studied isoform of HO.  It is a 32kDa enzyme that can 
be induced by a wide range of stimuli including pro-inflammatory cytokines, heavy metals, 
heat shock, hypoxia and oxidative stress.  As a result of its expression in response to stress, 
it  was  initially  identified  as  heat  shock  protein  32  (HSP32)  and  proposed  to  possess 
cytoprotective properties (Keyse and Tyrrell, 1989).
The proposed cytoprotective effects of HO-1  have been attributed to its enzymatic products. 
Biliverdin  and  bilirubin  have  both  been  shown  to  be potent  antioxidants  (Stocker  et al., 
1987; Marks et al.,  1991) whereas the free iron that is released induces the upregulation of 
ferritin, a protein which sequesters iron within a cell.  The net effect of ferritin is to decrease 
intracellular free iron concentrations, which prevents the production of ROS via the Fenton 
reaction.
Carbon monoxide also has been proposed to possess cytoprotective actions.  In vitro studies
using  cultured murine  fibroblasts  have  shown that the  overexpression  of HO-1  is  able to
prevent TNFa-induced apoptosis.  This effect can also be reproduced by the administration
of exogenous  CO  gas  (Petrache  et al.,  2000).  In  studies  of organ  transplantation,  pre-
51treatment of the organ with CO prevents organ rejection (Sato et al., 2001).  Furthermore, in 
models  of ischaemia/reperfusion  (I/R)  lung  injury,  HO-1  null  mice  displayed  increased 
mortality  compared  with  wild-type  mice.  This  was  partly  attributed  to  the  lack  of CO 
production from HO-1  because inhalation of CO gas (lOOOppm) compensated for the HO-1 
deficiency and improved survival following I/R injury (Fujita etal., 2001).
1.3.1.2  Haem Oxygenase-2 and -3
Haem oxygenase-2 is the isoform that is predominantly found in the brain (Sun etal., 1990) 
and  vasculature  where  it  has  been  proposed  to  be  involved  in  neurotransmission  and 
regulation  of  vascular  tone,  respectively  (Maines,  1997).  Unlike  HO-1,  HO-2  is  a 
constitutive  isoform.  They  are  products  of different  genes  and  share  little  similarity  in 
primary  structure,  regulation  and  tissue  distribution.  However,  they  have  similar 
mechanisms of haem catabolism, substrate specificity and coenzyme requirements.  Haem 
oxygenase-2 is a slightly larger protein (36kDa in size) and has a lower affinity for haem 
(Km  = 0.24pM for HO-1, Km  = 0.67pM for HO-2; Maines et al., 1986).  In addition, the HO- 
2 gene does not contain consensus sequences for the binding of several regulatory factors, 
including  heat  shock  factor,  AP-1  and  NF-kB.  This  explains  why  it  is  not  induced  by 
stimuli that induce HO-1  expression.
Little is known about HO-3.  It is a homologue of HO-2 that shows little catalytic activity 
and its functions are not well understood (McCoubrey etal., 1997).
521.3.2  Targets of Carbon Monoxide
Carbon monoxide, like NO, is able to bind to iron centres of haem groups (Maines,  1997). 
Unlike  NO,  however,  CO  only  has  affinity  for  ferrous  iron  whereas  NO  is  capable  of 
binding both the ferrous and ferric forms (Ryter et al., 2004).  It is through this interaction 
with haem groups that CO mediates most of its biological actions.
1.3.2.1  Soluble Guanylate Cyclase
Carbon  monoxide  activates  sGC  with  a  potency  30-100  times  less  than  that  of  NO 
(Furchgott &  Jothianandan,  1991).  Nevertheless  CO  has  been  shown  to  be  important  in 
stimulating sGC, particularly in the olfactory neurones of the brain.  These neurones do not 
express  NOS  but  still  produce  cGMP,  which  can  be  inhibited  by  either  haemoglobin  (a 
scavenger  of both  NO  and  CO)  or zinc  protoporphyrin  EX  (ZnPPIX;  an  inhibitor  of HO 
activity).  Furthermore, cGMP production could be stimulated by treatment with exogenous 
CO (Ingi et al.,  1996b).  These observations suggest a role for CO as an agonist for sGC in 
the brain.  In  contrast,  however,  CO has  also been  proposed to  be an antagonist of sGC. 
This is because production of cGMP in the cerebellar granules of the brain can be decreased 
by inhibition of NOS,  indicating that NO  is activating sGC, and increased by inhibition of 
HO  activity.  This  suggests  that  CO  could  be  acting  as  an  antagonist,  preventing  sGC 
activation by NO (Ingi etal., 1996a).
Carbon monoxide also modulates vascular tone via activation of sGC (Zakhary et al., 1996).
In these studies, it was shown that tin protoporphyrin IX, another inhibitor of HO activity,
reduced the vasorelaxation of porcine aortae in response to acetylcholine.  Furthermore, in
an  isolated  perfused  rat  liver  model,  inhibition  of  HO  activity  by  ZnPPIX  increased
53perfusion pressure.  This effect was reversed by the administration of either CO or cGMP 
analogues (Suematsu etal., 1994).
1.3.2.2  Mitogen-Activated Protein Kinase Pathways
The mitogen-activated protein kinase (MAPK) pathways  are  involved  in the signalling of 
stress and inflammatory events.  The MAPKs are a family of Ser/Thr protein kinases that are 
activated by a variety of stimuli (Kyriakis & Avruch,  1996).  There are three main MAPK 
pathways: extracellular signal-related protein kinase (ERK), JNK and p38 MAPK.  Carbon 
monoxide activates the p38 MAPK pathway and increases the phosphorylation of p38.  It is 
through this  mechanism that CO  has  been  proposed to exert  its  anti-inflammatory  effects 
(Otterbein et al., 2000).
1.3.2.3  The Electron Transport Chain
Carbon monoxide is also known to interact with the ETC by binding to complex IV.  Unlike 
NO, which can bind to the cytochrome a3 of complex IV in both the reduced and oxidised 
state, CO can only bind to it in the reduced state (Hansen & Nicholls,  1978; Haab,  1990; 
Piantadosi,  2002).  By  binding  to  complex  IV  CO  inhibits  the  catalytic  activity  of the 
enzyme  (Ki  =  0.32pM;  Petersen,  1977),  preventing  the  reduction  of  O2  to  water,  and 
therefore inhibiting the consumption of O2 by mitochondria.  This inhibition is competitive 
with O2 (Hansen & Nicholls,  1978).  Thus, when O2 is plentiful, CO is unable to bind onto 
complex IV.  In addition, when O2 is abundant complex IV  is maintained  in the oxidised 
state,  again  preventing  the  binding  of  CO.  In  situations  of  hypoxia,  where  the  O2 
concentration  is  low and  complex  IV  is  in  a  more  reduced  state  (Kreisman  et al.,  1981;
54Palacios-Callender et al., 2004), the binding of CO to complex IV is favoured (Wohlrab & 
Ogunmola, 1971; Piantadosi, 2002).
In  studies  of smokers,  who  experience a greater exposure to  CO,  it has  been  shown  that 
complex  IV  activity  in  blood  lymphocytes  was  inhibited  by  up  to  76%  compared  with 
controls  (Miro  et al.,  1998).  Other  complex  activities  remained  unaffected.  Following 
cessation of smoking for 3 days, complex IV activity recovered to 48% of control levels.
551.4  Hypoxia
Hypoxia is generally defined as the lack of availability of O2, whether it be for the alteration 
in cellular bioenergetics due to the changes in mitochondrial and glycolytic activity, or for 
the initiation of adaptive transcriptional events.  In biological systems, adaptation to hypoxia 
has  been  associated  with  an  alteration  in  gene  transcription,  specifically  with  the 
upregulation  of  genes  that  promote  survival  in  low  O2  conditions,  such  as  the 
haematopoietic growth factor erythropoietin, and those that alter the energy metabolism of a 
cell to a more anaerobic state, such as the enzymes that are involved in glycolysis (Semenza, 
2003).  Investigations  into  the  mechanism  by  which  these  genes  are  induced  led  to  the 
identification of a transcription factor that is responsive to low O2 concentrations: hypoxia- 
inducible factor.
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that is  composed of 
two  subunits:  HDFa  and  HEF|3.  Whereas  HIFp  is  a  constitutive  protein,  HIFa  is  highly 
induced  by  hypoxia.  In  hypoxia  HIFa  and  HIF|3  dimerise  to  form  the  active  HIF 
transcription factor.  This is then able to recognise and bind onto specific DNA sequences 
(5’-G/ACGTG-3’; Semenza,  1996) in the promoter or enhancer regions of genes to initiate 
transcription.  These DNA motifs are called hypoxia-response elements (HREs).
There  are  three  isoforms  of HIFa,  each  a  product of separate  genes:  HIFla,  HIF2a  and
HIF3a.  The  isoform  that  displays  the  most  robust  response  to  hypoxia,  and  has
subsequently  been  most  studied  and  understood,  is  HIFla.  In  addition,  the  active
heterodimer  of HIFla,  HEFl,  has  been  proposed  to  be  the  most  important  transcription
factor regulating gene expression in hypoxia (Sandau etal., 2001).
561.4.1  Hypoxia-lnducible Factor 1a
Hypoxia-inducible factor la is a 120kDa protein that dimerises with HIF 1(3 to form HIF1, 
which has been reported to control the expression of over 60 genes (Semenza, 2003).  It is 
stabilised in hypoxia in most, if not all, cells.
Hypoxia-inducible factor  la protein is  induced exponentially by O2 concentrations of less 
than 6% (Jiang et al.,  1996), but the mRNA levels are not upregulated (Wood et al.,  1996). 
This  suggests  that HIFla protein  is  not regulated by hypoxia at the  transcriptional  level. 
When O2 is abundant, the HIFla protein is rapidly degraded and is subsequently unable to 
dimerise with HIF 1(3 to form the active HEFl  transcription factor.  In hypoxia the protein is 
no  longer degraded and  is  stabilised.  The mechanism by which the stability  of HIFla  is 
regulated involves the prolyl hydroxylase enzymes (Figure 4).
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Figure 4.  Prolyl hydroxylation of HIFla targets the protein for degradation.  The hydroxylation of
two  specific proline residues  in HIFla is catalysed by the  enzyme prolyl  hydroxylase.  This enzyme 
requires  the  substrates  0 2  and  2-oxoglutarate  (2-OG)  to  function,  as  well  the  presence  of iron  and 
ascorbate.  The prolyl hydroxylation of HIFla results in the binding of the von Hippel Lindau tumour 
suppressor protein  and E3  ligase,  which  catalyses the  polyubiquitination  of HIF 1  a.  This targets the 
transcription factor for proteasomal degradation.
1.4.2  HIFla Regulation by Prolyl Hydroxylases
When 0 2 is abundant HIFla is rapidly targeted for degradation via hydroxylation of specific 
proline residues (Pro402 and Pro564; Bruick and McKnight, 2001) located in the carboxy- and 
amino-terminal  oxygen-dependent  degradation  domains  of  the  protein  (CODDD  and 
NODDD,  respectively).  These reactions are catalysed by the prolyl hydroxylase enzymes, 
which  are  members  of  the  2-oxoglutarate-dependent-oxygenase  family  (Schofield  and 
Ratcliffe, 2004).  Hydroxylation of the prolyl residues increases the affinity of HIFla for the
58von  Hippel-Lindau  tumour suppressor protein  (pVHL;  Ivan  et al.,  2001;  Jaakkola  et al.,
2001) which recruits E3 ubiquitin-protein ligase (Maxwell et al., 1999).  This ligase enzyme 
catalyses the polyubiquitination of the hydroxylated HIFla protein, which ultimately results 
in its degradation via the ubiquitin-proteasome pathway.  In addition, acetylation of HIFla 
at Lys532 has  been reported to enhance the interaction of prolyl-hydroxylated HIFla with 
pVHL.  This  acetylation  reaction  is  catalysed  by  ARD1  acetyltransferase  (Jeong  et al.,
2002).
The  initial  step  in  this  sequence  of events,  the  prolyl  hydroxylation,  is  an  02-dependent 
reaction  which  utilises  O2  for  two  purposes:  to  hydroxylate  HIFla  and  to  oxidatively 
decarboxylate  2-oxoglutarate  into  succinate  and  CO2.  This  reaction  is  rapid  and  occurs 
when  O2  is abundant,  preventing the  formation of HIF1  and  subsequent gene  expression. 
When  O2  becomes  limiting  the  enzyme  activity  is  inhibited  and  HIFla  is  no  longer 
hydroxylated  and  is  not,  therefore,  targeted  for  degradation.  The  Km   of  the  prolyl 
hydroxylases  for O2  has  been  reported  to  be  in  the region of 230-250pM (Hirsila  et al., 
2003), explaining the lack of HIFla prolyl hydroxylation at low (<3pM) O2 concentrations. 
It  has  been  proposed  that  such  a  high  Km   renders  the  prolyl  hydroxylases  sensitive  to 
changes in O2 concentration and therefore makes them good cellular O2 sensors.
Three isoforms of the HIF prolyl hydroxylase enzymes have been identified: PHD1, PHD2 
and PHD3.  Of these, it has been shown that inactivation of PHD2 is enough to upregulate 
HIFla  (Berra  et al.,  2003).  However,  transfection  studies  have  shown  that  each  of the 
prolyl  hydroxylases  have  the  ability  to  regulate HIFla protein  levels  in  cells  (Bruick  & 
McKnight, 2001).
591.4.3  Regulation by Asparaginyl Hydroxylases
In addition to prolyl hydroxylation, HIF la may also be subject to hydroxylation on Asn803. 
This reaction is catalysed by an enzyme called factor inhibiting HIF (FIH).  FIH requires the 
same  co-substrates  (O2  and  2-oxoglutarate)  as  the  prolyl  hydroxylases  but  has  a  greater 
affinity for them (the Km  for O2 is 90pM, 230-250pM for prolyl hydroxylases, and the Km  
for 2-oxoglutarate is 25 pM, 55-60pM for prolyl hydroxylases).
The  hydroxylation  of  Asn803,  unlike  that  of the  pro line  residues,  does  not  initiate  the 
degradation of HIFla but prevents its association with transcriptional co-activators such as 
CBP/p300, resulting in a lower activity (Lando etal., 2003).  However, as a result of its high 
affinity for O2, FIH has been reported to inhibit HIF1  transcriptional activity even at very 
low O2 concentrations (Mahon etal., 2001).
1.4.4  Regulation by ROS
Two main hypotheses have been proposed whereby ROS may modulate the stability of the 
HIFla protein.  The first involves the NADPH oxidase enzyme and the second proposes a 
role for ROS derived from the ETC.
NADPH oxidase produces O2"  which is subsequently converted into H2O2 by SOD.  It has 
been proposed that a fall in O2 concentrations reduces the amount of ROS produced and that 
this  signals  for  HIFla  stabilisation  (Fandrey  et  al.,  1994).  This  is  supported  by  the 
observation that H2O2 inhibited the hypoxic stabilisation of HIFla (Huang et al., 1996) and
60that  the  administration  of  catalase  or  antioxidants  to  cells  induced  the  non-hypoxic 
stabilisation of HIFla (Salceda and Caro,  1997).  However, experimental results from other 
laboratories are inconsistent with this hypothesis, for example diphenylene iodonium, which 
inhibits  NADPH  oxidase  and  therefore  reduces  ROS  production,  prevents  the  hypoxic 
stabilisation of HIFla (Gleadle etal., 1995).
Other  studies  investigating  the  role  of  mitochondria  in  the  regulation  of  HIFla  have 
proposed that O2* , and subsequently H2O2, generated from the ETC are required to stabilise 
HIFla and to induce HIF1  activity (Chandel et al., 2000a; Agani et al., 2000).  It has been 
shown that under hypoxic conditions the ETC is shifted to a more reduced state because of a 
decrease in activity of complex IV due to a lack of O2 as its substrate (Palacios-Callender et 
al.,  2004).  This  change  in redox  state  increases the  ‘leak’  of electrons  to  O2 from  other 
complexes  of the ETC,  probably  complex  III,  to  form  0 {  which  initiates  the  signal  for 
HIFla  stabilisation  (Chandel  et al.,  2000a).  In  support  of this  hypothesis,  a  number  of 
antioxidants  (N-acetylcysteine  and  glutathione)  have  been  shown  to  inhibit  the  hypoxic 
stabilisation of HIFla.  In contrast,  however, the use of complex IV inhibitors  (azide and 
cyanide), to mimic the decreased activity of the enzyme in hypoxia, have been reported not 
to inhibit HIF1  activity (Chandel et al.,  1998), and antimycin a, a complex HI inhibitor that 
causes ROS production from this site, does not induce non-hypoxic stabilisation of HIFla. 
These  observations  disagree  with  the hypothesis.  In  addition,  the  precise  mechanism by 
which ROS may modulate HIFla stabilisation has remained elusive.
611.4.5  Regulation by Nitric Oxide
Nitric oxide has been reported both to promote and inhibit the stabilisation of HIFla (Huang 
et ah,  1999; Metzen et al, 2003).  Upon hypoxic stabilisation of HIFla, treatment of cells 
with NO, derived from NO donors, induces the destabilisation of the protein (Sogawa et ah, 
1998; Agani et ah, 2002) and a reduction in DNA binding through a mechanism that does 
not involve sGC (Huang et ah,  1999).  In contrast, however, HIFla can be stabilised by NO 
under non-hypoxic conditions (Sandau etal., 2001).
A variety of explanations have been proposed for the mechanism by which NO  stabilises 
HIFla  protein.  One  hypothesis  suggests  that  it  may  act  through  S-nitrosylation  of the 
protein which subsequently prevents its degradation (Palmer et ah,  2000;  Sumbayev et al.,
2003).  However, this mechanism has been questioned because of a lack of a specific target 
for NO  in  the  HIFla  protein.  Alternatively,  NO  can  inhibit prolyl  hydroxylase  activity, 
preventing the degradation of HIFla protein.  It has been proposed that NO  can compete 
with  O2  for  binding  to  the  iron  in  the  active  site  of the  enzyme  (Metzen  et ah,  2003). 
However,  other  studies  have  reported  that  NO  can  increase  the  prolyl  hydroxylation  of 
HIFla (Wang etal., 2002).  In addition, NO may stabilise HIFla protein by increasing the 
production of ROS (Genius & Fandrey, 2000).
Recently,  it  has  been  shown  that  the  contrasting  effects  of  NO  may  be  due  to  the 
concentration at which  it is used,  and that there  is actually a biphasic  effect of NO  upon 
HIFla  stability,  with  low concentrations  destabilising  and  high  concentrations  stabilising 
HIFla.  Furthermore,  it has been  proposed  that the  HIFla  destabilising  effect  of NO  is
62mitochondria-dependent whereas the stabilising effect is mitochondria-independent (Mateo 
etal., 2003).
63AIMS
A number of studies have demonstrated that exogenous NO can cause both a reversible and 
persistent  inhibition  of cellular  respiration.  Thus,  the  initial  aims  of my  work  were  to 
confirm that:
•  acute  treatment  with  exogenous  NO  rapidly  and  reversibly  inhibits  cellular 
respiration, and
•  prolonged exposure to NO can persistently inhibit cellular respiration, and that this 
phenomenon is associated with a decrease in complex I activity.
To verify that endogenous NO can also inhibit respiration, both reversibly and persistently, a 
macrophage-like cell line was activated to produce NO and the effects upon O2 consumption 
were followed over time.
Having established the effects of NO, I wanted to determine whether CO can inhibit cellular 
respiration.  CO has also been shown to inhibit complex IV of the ETC.  However, little is 
known about the ability of CO to inhibit cellular respiration.  Therefore, I wanted to:
•  clarify whether exogenous CO could inhibit respiration,
•  investigate  if,  by  transfecting  the  HO-1  gene  into  HEK293  cells,  endogenously- 
produced CO can inhibit respiration,
•  investigate  the  time  course  of HO-1  expression  in  activated  macrophages  and  to 
follow the effect that the CO has on the respiration of those cells,
•  investigate the relative contribution of NO and CO to the mitochondrial defect that 
occurs in activated macrophages both under ambient and hypoxic conditions.
64Although NO has been shown to potently inhibit cellular O2 consumption, the significance 
of this phenomenon is currently not well understood.  Recent evidence has indicated a link 
between  mitochondrial  respiratory activity  and the  stability  of HIFla  protein.  However, 
many of the reports have been contradictory and the precise mechanisms  involved remain 
unclear.  Therefore, to examine the consequences of respiratory inhibition, I aimed to:
•  clarify the role of mitochondria in the modulation of hypoxia-induced stability of 
HIFla protein,
•  investigate  the  mechanism  by  which  the  inhibition  of  mitochondrial  activity 
could be acting to affect this phenomenon.
652  MATERIALS AND METHODS
6 62.1  Growth and Maintenance of Cell Lines
Unless  otherwise  stated,  cells  were  grown  and  maintained  in  appropriate  culture  media 
supplemented  with  10%  heat-inactivated  (30mins  at  56°C  and  then  cooled  on  ice)  New 
Zealand  foetal  bovine  serum,  2mM  L-glutamine,  lOOU/ml  penicillin  and  100pg/ml  of 
streptomycin (Life Technologies, Paisley, U.K.).  They were kept in an incubation chamber 
set at 37°C with 95% air and 5% CO2.
2.1.1  Culture of RAW264.7 Cells
RAW264.7 (murine monocyte) cells  were obtained from American Type Culture Collection 
(Manassas, VA).  They were maintained as described above in RPMI  1640 medium  (Life 
Technologies, Paisley, U.K.).  Cells were grown as a suspension culture in biological stirrer 
bottles (Techne, Cambridge, UK) set with a continuous stirrer speed of 25rpm.
2.1.2  Culture of HEK293, Hep3B, 143B and HeLa Cells
HEK293  (human  embryonic  kidney),  Hep3B  (human  hepatoma),  143B  (human 
osteosarcoma)  and  HeLa  (human  cervix  carcinoma)  cells  were  cultured  in  DMEM  (Life 
Technologies,  Paisley,  U.K.).  They  were  grown  in  T175  tissue  culture  flasks  (Becton 
Dickinson, Franklin Lanes, N.J.) and kept below 90% confluency.
2.2  Measurement of O2 Consumption
Oxygen consumption was  measured polarographically through the use of a Clark-type O2
electrode  (Figure  5;  Rank Brothers,  Bottisham,  U.K.)  which  was  equipped  with  a  water
67jacket  thermostatically  set  at  37°C.  Prior to  use,  the  electrode  was  calibrated  with  air- 
saturated water, assuming an O2 concentration of 200pM.
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Figure 5.  The Clark-type 0 2 electrode.  The illustration shows a Clark-type 0 2  electrode that was
used to measure cellular 0 2 consumption.  Cells (at a concentration of 107 /ml) were sealed inside the 
incubation chamber and the decrease of 0 2 was measured by the electrode and recorded by the DUO 18 
program.
Samples  (1ml  of cells suspended  in incubation medium at a concentration of 107cells/ml) 
were  placed  into  a  gas-tight  chamber  which  was  sealed  using  a  plastic  plunger.  A 
homogeneous  sample  was  maintained  by  a  magnetic  stirrer  (Rank  Brothers,  Bottisham, 
U.K.)  situated  at  the  bottom  of the  chamber,  set  at  600rpm.  The  decrease  of O2  (O2 
consumption)  was  recorded  using  the  DU018  (World  Precision  Instruments,  Stevenage, 
U.K.) recording system.
6 8Treatments were administered to the cells within the incubation chamber through the use of 
a microsyringe, which was inserted into the chamber via a port in the plunger.
2.3  Activation of RAW264.7 Cells
RAW264.7 cells were activated using LPS (lOOng/ml; Sigma) and IFNy (50U/ml).  Both LPS 
and IFNy were prepared in phosphate buffered saline solution and were added to the cells, 
which were in biological stirrer bottles.
2.4  Measurement of NO
Nitric oxide was measured either by an NO electrode or by the Griess assay, as described 
below.
2.4.1  Use of an NO Electrode
Nitric oxide was measured amperometrically through the use of an ISO-NOP NO electrode 
(Figure 6; World Precision Instruments, Stevenage, U.K.).  Prior to use, the electrode was 
calibrated  by  generating  known  amounts  of NO  via  a  chemical  reaction.  The  chemical 
reaction used was:
2KN02 +2KI + 2H2S04 -> 2NO + I2 + H20  + K2S04
69Since the amount of NO  produced by the reaction  is proportional to  the amount of KNO2 
added,  when KI and H2S04 are in excess, then known amounts of NO can be generated by 
adding known quantities of KN02 (Figure 7).
The NO electrode was positioned in the incubation chamber of the 0 2 electrode via a port in 
the  plunger  such  that  both  NO  and  0 2  concentrations  could  be  measured  simultaneously 
during experiments.
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Figure 6.  The structure of an NO electrode.  Dynamic NO concentrations were measured using an
NO  electrode  which  was  calibrated  prior to  use.  The  electrode  was  positioned  into  the  incubation 
chamber  of the  Clark-type  0 2   electrode  through  a  port  in  the  plunger  such  that  both  0 2  and  NO 
concentrations were measured simultaneously.
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Figure 7.  Calibration  of the  NO  electrode,  (a)  A  tracing  obtained  from  the  DU018  recording
program during the calibration of the NO electrode.  Nanomolar concentrations of nitrite (indicated by 
arrows  and numerical  values) were  added to the reaction mixture consisting of potassium  iodide  and 
sulphuric acid.  The current detected from the reaction is proportional to the concentration of nitrite (and 
NO) present,  (b) A calibration curve was plotted such that nitrite (and hence, NO) concentrations could 
be calculated from the currents measured,  (n = 3).
712.4.2  Griess Assay
Nitric oxide was also quantified indirectly by measuring the concentration of NO2', a stable 
metabolite of NO.  Under acidic conditions, NO2"  produces  a nitrosating agent that reacts 
with sulphanilamide to produce a diazonium cation.  This cation can then react with N-(l- 
naphthyl)ethylenediamine  dihydrochloride  to  produce  an  azo  compound  of  a  purple 
colouration (Figure 8).  The absorbance of this azo compound at 540nm is proportional to its 
concentration  (Figure  8b)  and  can  be  used  to  quantify  NO2'  concentrations  in  unknown 
samples (Green et al.,  1982).  This assay can detect NO2’ concentrations as low as  lOOnM 
(Nagano, 1999).
The procedure was as follows: equivolume quantities of 1% sulphanilamide (acidified in 5% 
phosphoric  acid)  and  0.1%  N-(l-naphthyl)ethylenediamine  dihydrochloride  (dissolved  in 
water)  were  mixed together to  form the  Griess  reagent.  Aliquots  (lOOpl)  of this  reagent 
were mixed with  100pi  of a sample  in a 96-well plate and the absorbance was  measured 
immediately.
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Figure 8.  The  reactions  of the  Griess  assay,  (a)  Sulphanilamide  reacts  with  the  nitrite  anion  to
produce a chemical species that reacts with N-(l-naphthyl)ethylenediamine dihydrochloride (NED) to 
produce an azo compound.  This azo compound has a strong absorbance at 540nm.  (b) A calibration 
curve obtained from the Griess assay using known concentrations of nitrite solutions.  The absorbance 
measured was directly proportional to the concentration of nitrite,  n > 3.
2.5  Measurement of Complex I Activity
Complex  I  activity  was  determined  spectrophotometrically  (Uvikon-XS,  Biotek, 
Loughborough,  U.K.)  by  the  rate  of rotenone-sensitive  NADH  oxidation  (King,  1967). 
Cells  were  collected  and  centrifuged  at 2500g  for  5mins.  The  resultant  pellet  was  then 
resuspended  in  100pi  of potassium  phosphate buffer  (lOmM,  pH8.0)  and  subjected  to  3 
freeze-thaw cycles (frozen in liquid nitrogen for 5mins and then warmed to 37°C in a water
73bath).  20pl aliquots of the cell lysates were added to 955pl of phosphate buffer containing 
50pM ubiquinoneio  (Sigma,  Poole,  U.K.).  Freshly prepared NADH (Sigma,  Poole,  U.K.) 
was then added to a final concentration of lOOpM and the formation of NAD+ was measured 
at  340nm  (e  =  6.81mM*1cm'1)  for  2mins.  To  the  same  sample,  5pM  rotenone  (Aldrich 
Chemicals  Company,  Milw.,  WI)  was  added  to  distinguish  the  production  of NAD+  by 
complex I from other cellular processes.  The difference in the rates of oxidation of NADH 
in the presence and absence of rotenone was due to the activity of complex I.  The assayed 
sample  was  then collected  and the protein  content was  measured  using the bicinchoninic 
acid method (described below).  Complex I activity was expressed as nanomoles of NAD+  
produced per minute per milligram of protein.
2.6  Measurement of Complex IV Activity
Complex  IV  activity  was  determined  spectrophotometrically  by  the  rate  of oxidation  of
reduced  cytochrome  c  (Wharton  and  Tzagoloff,  1967).  Prior  to  analysis,  samples  were
prepared as described for measurement of complex I activity.  Bovine cytochrome c (Sigma,
St. Louis, MO) was dissolved in phosphate buffered solution (lOOmM, pH7.0) at an initial
concentration  of 4g/100ml  buffer and  was  reduced  by the addition  of a  small  amount of
sodium dithionite.  The solution was then passed through a sephadex G25 (Sigma, St. Louis,
MO)  column  to  purify the  solution  and  the  eluent  was  collected.  The  concentration  of
reduced cytochrome c was determined spectrophotometrically at 550nm (s =  19.6mM'1cm'
l).  Cytochrome c (150pl) was added to cellular extracts (10pl; prepared by freeze-thaw lysis
of  cells  described  above)  in  840pl  buffer  and  the  rate  of  oxidation  was  measured
spectrophotometrically.  This  procedure  was repeated  in  the presence of azide (5mM)  to
distinguish the oxidation of cytochrome c by complex IV from that by other processes.  A
74graph of time against log(absorbance) was then plotted and the first-order rate constant was 
determined.  Protein concentrations were measured in the original samples and complex IV 
specific  activity was  calculated  from the  known cytochrome c concentration  in the  assay 
mixture and the first-order velocity constant.  Specific activity was expressed as nanomoles 
of cytochrome c oxidised per minute per milligram of protein.
2.7  Measurement of Protein
Protein  concentrations  in  samples  were  quantified  using  the  bicinchoninic  acid  (BCA) 
protein assay reagent kit (Pierce, Illinois, U.S.A.).  This assay is based on the reduction of 
cupric (Cu2+) cations into the cuprous (Cu+) ion by proteins under alkaline conditions.  The 
Cu+ ions then  chelate with BCA resulting  in the formation of a purple-coloured  complex 
whose absorbance at 562nm is proportional to protein concentrations from 0.02-2mg/ml.
Albumin standards of known concentrations were prepared alongside unknown samples that 
were  diluted appropriately.  The assay reagent was  prepared by  mixing  50 parts  of BCA 
reagent A with 1 part BCA reagent B.  200pi of the assay reagent was then mixed with 25pl 
of  standard  or  unknown  on  a  microplate  and  incubated  for  30mins  at  37°C.  After 
incubation,  the  absorbance  was  measured  using  a  microplate  reader  and  the  protein 
concentrations of the unknowns were obtained from the standard curve plotted.
2.8  Measurement of Bilirubin
In  experiments  where bilirubin  was  measured,  the  culture  vessel  was  wrapped  in  foil  to 
protect it from light.  Treatments were performed and 1ml aliquots of culture medium were
75collected at the allotted timepoints.  The aliquots were then centrifuged for 5’ at 13000rpm 
to remove any cells or debris.  A 0.5ml sample was collected from the resultant supernatant 
and  added  to  250mg  of BaCh.  The  mixture  was  then  vortexed  vigorously  prior  to  the 
addition of 0.75ml benzene.  The mixture was vortexed again and then centrifuged for 30’ at 
13000rpm.  The upper benzene layer,  containing the bilirubin,  was  then extracted and its 
absorbance  was  measured  at  450nm  with  a  reference  at  600nm.  The  concentration  of 
bilirubin in the sample was then calculated using the molar extinction coefficient of bilirubin 
dissolved in benzene,  8450  = 27.3mM'1 cm’1  (Foresti et al., 1999).  A separate sample of fresh 
culture medium was processed in the same way and used as a blank.
2.9  Western Blotting
Cells  were  lysed  using  an  ice-cold  lysis  buffer  containing  25mM  Tris  (pH7.5),  2.5mM 
EDTA,  2.5mM  EGTA,  20mM  NaF,  ImM  sodium  orthovanadate,  lOOmM  NaCl,  20mM 
sodium  |3-glycerophosphate,  lOmM  sodium  pyrophosphate,  0.5%  triton,  0.1%  (3- 
mercaptoethanol  and  complete  protease  inhibitor  cocktail  (Roche,  Lewes,  U.K.).  For 
detection of HIFla protein, cells were lysed in an ice-cold buffer consisting of lOmM Hepes 
(pH7.5),  1.5mM MgCh,  lOmM KC1, 0.2% NP-40,  0.2%  2-mercaptoethanol  and complete 
protease inhibitor cocktail (Roche, Lewes, U.K).  The lysates were vigorously vortexed and 
then  centrifuged  for  5mins  at  5000rpm  to  remove  cellular  debris.  The  supernatant  was 
collected and analysed for protein concentration.  Samples were either used immediately or 
stored at -80°C for future use.  Frozen samples were thawed gently on ice and then vortexed 
briefly to obtain a homogeneous lysate.
762.9.1  Protein Separation by SDS-PAGE
Equal  amounts  of  protein  (50pg)  were  prepared  for  electrophoresis  under  reducing 
conditions  by  mixing one  part sample  with  three  parts  Laemmli  sample  buffer (Bio-rad) 
containing  5%  2-mercaptoethanol  (Sigma).  For example,  a  5pi  aliquot of a  sample  was 
mixed with  15pl of sample buffer.  The mixture was then boiled  at  100°C  for 5mins  and 
cooled on ice for a further 5mins.
Once cooled,  the samples  were  loaded  into  separate  wells  of a sodium  dodecyl  sulphate- 
polyacrylamide gel (SDS-PAG) along with a well containing standard protein markers.  The 
proteins then underwent electrophoresis (SDS-PAGE) at  125V for approximately  1.5hrs or 
until the solvent front reached the bottom of the gel.  The stacking and resolving gels and the 
running buffer were prepared as follows:
Stacking gel:  5ml of a 5% stacking gel was prepared by mixing 3 .4ml
distilled water, 0.83ml 30% acrylamide mix, 0.63ml 1.0M 
Tris (pH6.8), 0.05ml 10% SDS, 0.05ml 10% ammonium 
persulphate and 0.005ml TEMED.
Resolving gel:  20ml of an  8%  resolving gel was  prepared  by mixing 9.3ml
distilled water, 5.3ml 30% acrylamide mix, 5.0ml 1.5M 
Tris (pH8.8), 0.2ml 10% SDS, 0.2ml 10% ammonium 
persulphate and 0.012ml TEMED.
20ml of a  12%  resolving gel was  prepared by mixing 6.6ml 
distilled water, 8.0ml 30% acrylamide mix, 5.0ml 1.5M 
Tris (pH8.8), 0.2ml 10% SDS, 0.2ml 10% ammonium 
persulphate and 0.008ml TEMED.
77Running buffer:  3g Trizma base, 15 glycine and lg lauryl sulphate were
dissolved in distilled water and made up to a final volume 
of 11.
2.9.2  Protein Transfer onto Nitrocellulose Membranes
Once the proteins had been separated, the gel was removed from the electrophoresis cassette 
and transferred onto a nitrocellulose membrane (Amersham Life Science, Bucks,  U.K.)  at 
25V  for  12h  at  4°C.  The  gel  was  positioned  in  a  cassette  next  to  the  nitrocellulose 
membrane and between fibre pads and filter paper (Whatman, U.K.) as illustrated (Figure 9). 
The entire apparatus was immersed in cooled (4°C) transfer buffer consisting of 3 .1 g Trizma 
base, 14.4g glycine, 200ml methanol and made up to 11 with distilled water.
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Figure 9.  Protein transfer onto nitrocellulose membrane.  The diagram illustrates the set up of the
cassette for the transfer of proteins from a polyacrylamide gel onto a nitrocellulose membrane.
2.9.3  Immunoblotting of Proteins
Once  transferred,  the  nitrocellulose  membrane  was  initially  blocked  in  10%  non-fat  milk 
protein (Marvel)  in TBS-T (6.6g NaCl, 25ml  1M Tris HC1  (pH7.5),  0.05% Tween 20 and 
made up to  11 with distilled water) for 60mins.  The membrane was then washed in TBS-T 
for  15mins and incubated with a primary antibody in TBS-T for 60mins.  After incubation, 
the membrane was  again washed for  15mins and incubated with  a horseradish peroxidase
79(HRP)-conjugated secondary antibody in  5% milk in TBS-T  for 60mins.  The membrane 
was then washed one final time in TBS-T.
Immunoreactive  bands  were  visualised  by  incubating  the  membrane  with  ECL  reagent 
(Amersham  Life  Science,  Bucks,  U.K.)  for  lmin  and  then  exposing  the  membrane  to 
autoradiography film  (Amersham Life  Science, Bucks, U.K.)  for 30s and  lmin.  Exposed 
films were then developed using a developer.
Rabbit  polyclonal  antibodies  were  used  to  detect  HO-1  (Stressgen  Biotechnologies)  and 
iNOS (BD Transduction Laboratories).  An anti-rabbit HRP conjugate (Vector Laboratories) 
was used as the secondary antibody.
To detect HIFla a monoclonal antibody (BD Transduction Laboratories, Oxford, U.K.) was 
used.
Measurement of p38 MAPK activity was determined by detection of phosphorylated p38 via 
Western  blotting  using  a  commercially  available  kit  (PhosphoPlus  p38  MAP  Kinase 
Antibody Kit, Cell Signalling Technology).
2.10  Preparation of CO Solutions
Fresh  stock  solutions  of CO  gas  were  prepared  each  day  by  the  method  described  by
Naseem and Bruckdorfer,  1995.  Briefly, double distilled water was boiled for 15min, and
allowed  to  cool  to  60°C  whilst  being  pulled  under  vacuum  into  specially  adapted  gas
sampling  tubes.  10ml  of the  water  was  then  flushed  with  nitrogen  gas  (BOC  Gases,
80Guildford,  U.K.)  for  45min  and  the  container  tubes  were  sealed  with  gas-impermeable 
rubber  septa.  CO  gas  (BOC  Gases,  Guildford,  U.K.)  was  then  bubbled  into  the  flushed 
solutions  for  lh.  The  concentration  of  CO  in  solution  was  determined 
spectrophotometrically  by  measuring  the  conversion  of  deoxymyoglobin  to  carbon 
monoxymyoglobin.
2.11  Measurement of CO Concentrations
The method used to measure the concentration of CO in water was similar to that described 
previously by Motterlini et al. (Motterlini et al., 2002).  The method utilised the binding of 
CO  to  deoxymyoglobin  to  form  carbon  monoxymyoglobin,  whose  concentration  can  be 
determined spectrophotometrically with an absorbance at 540nm (s54o = 1  S^mM^cm'1).
Fresh deoxymyoglobin solutions (66 pM) were prepared by dissolving the protein in 0.04M 
phosphate buffer (pH6.8).  Prior to use, the reducing agent sodium dithionite (~5mg) was 
added  to  the  deoxymyoglobin  solution  to  completely  reduce  it.  CO  solutions  were  then 
mixed with the deoxymyoglobin and left for lmin before spectrophotometric measurement.
2.12  Determination of Kj Values
In order to calculate the Ki values of CO for complex IV, Lineweaver-Burk and secondary 
plots were constructed.  The reaction velocity (rate of O2 consumption) was measured in the 
presence  of  a  fixed  concentration  of  inhibitor  (CO)  and  varying  substrate  (O2) 
concentrations.  The velocity was then plotted against the substrate concentration in a double 
reciprocal  (Lineweaver-Burk)  plot.  The  slopes  obtained  were  then  plotted  against  the
81inhibitor concentrations (secondary plot).  The K; was  calculated by interpolation to the x-
axis.
2.13  Incubation under Hypoxia
Experiments that were performed under hypoxic (1% O2) conditions were carried out within 
a humidified anaerobic chamber (Coy Laboratory Products; Grasslake, MI).  The chamber 
was  digitally  set  at  the  required  O2  concentration  and  was  maintained  at  37°C  by  a 
thermostatic controller.
2.14  Generation of HEK293-HO-1 Cells
Full length human HO-1  was amplified via PCR from human foetal brain cDNA.  An Xhol 
restriction site and Kozak consensus sequence (GACGAG) was included in the PCR primers 
at  the  5’  end,  and  Xbal  site  at  the  3’  end.  The  following  PCR  primers  were  used. 
C  ACTCGAGGACGAGAT GGAGCGTCCGC  AACCCG  (forward)  and
C  ATCT  AGATT AC  AT  GGC  AT AAAGCCCT  AC (reverse).  The PCR product was then gel 
purified and, after addition of an A overhang, subcloned into pGEM-T easy.  The sequence 
was confirmed by DNA sequencing, and the HO-1  gene was transferred to the pcDNA4/TO 
plasmid, using the Xhol and Xbal restriction sites.  TREX293  cells (tet-on HEK293  cells) 
were then  transfected  with  the  HO-l-pcDNA4/TO  expression  plasmid,  and  stable  clones 
were isolated using zeocin selection.
822.15  Measurement of HIF1 Gene Reporter Activity
The activity of the HIF1  transcription factor was assessed by an HRE-dependent luciferase 
reporter assay.  The pGL3-HRE luciferase reporter construct that was used was a kind gift 
from  Dr.  Kaye  Williams  (The  School  of  Pharmacy  and  Pharmaceutical  Sciences, 
Manchester, U.K.).  It contains three copies of the HRE from the phosphoglycerate kinase 
promoter, located upstream of a luciferase gene.
Cells  were  cultured  in  12-well  plates  until  approximately  50%  confluency  and  then 
transfected with 0.2pg/ml of pGL3-HRE DNA for 24h.  The cells were then incubated for 
5h at 1% O2 in the absence or presence of respiratory inhibitors.  The resultant luciferase 
activity  was  then  assayed  using  the  Steady-Glo  Luciferase  Assay  System  (Promega, 
Southampton,  U.K.).  Luminescence  was  detected  using  a  luminometer  (Berthold 
Technologies,  Bad  Wildbad,  Germany)  and  was  expressed  as  relative  fold-increase 
compared with non-hypoxic control cells.
2.16  Measurement of 0 2 -Dependent Renilla Luciferase Activity
2.16.1  Construction  of  a  Mitochondrially-Targeted  Renilla
Luciferase Vector
The  Renilla  luciferase  gene  was  obtained  from  the  pRL-CMV  vector  (Promega,
Southampton,  U.K.).  A  V5  epitope  tag  was  added  and  the  sequence  was  amplified  via
polymerase chain reaction (PCR).  The PCR product was then subcloned into the Xhol and
Xbal sites of the pcDNA3  vector (Invitrogen, Paisley, U.K.).  The mitochondrial-targeting
83sequence of MnSOD (SOD-2), comprising residues 1-28 of the gene, was generated by PCR 
amplification  and  a Kozak  consensus  sequence  was  added  at the  5’  end.  This  targeting 
sequence was then inserted into the Kpnl and Xhol sites of the pcDNA3 vector containing 
the Renilla luciferase gene to form the mtRLuc-pcDNA3 construct.
2.16.2  Transfection  and  Measurement  of  Renilla  Luciferase 
Activity in HeLa Cells
HeLa cells  were grown to 60-80% confluency on  10cm tissue culture plates.  They were 
then transfected with 2pg of the mtRLuc-pcDNA3  plasmid using Fugene 6 (Roche, Lewes, 
U.K.) following the manufacturer’s instructions.  The medium was then changed following 
overnight incubation and the cells were then left for a further 24h at 37°C.  They were then 
trypsinised,  centrifuged  and  resuspended  at  a  concentration  of 3  x  106cells/ml  at  1%  O2 
using preconditioned medium that was left at 1% O2 for 24h.  The cells were then divided 
into lOOpl aliquots and left to equilibrate for lOmins.  DETA (0-100pM) was then added to 
the cell suspensions and left for a further 60mins.  The luciferase substrate, coelenterazine- 
hcp  (Sigma,  Poole,  U.K.),  was then added at a final  concentration of 5pg/ml  and  left for 
5mins.  Renilla  luciferase  luminescence  in  the  cells  was  measured  using  a  hand-held 
luminometer (Berthold Technologies, Bad Wildbad, Germany).
2.16.3  Measurement  of  Immunoprecipitated  Renilla  Luciferase 
Protein
HeLa cells were transfected with the mtRLuc-pcDNA3 plasmid and maintained as described 
above.  Following trypsinisation,  the cells  were lysed using the HIFla  lysis buffer.  The
84lysates were then centrifuged for 5mins at 5000rpm and the supernatant was collected.  The 
lysates  were  mixed  with  2.5jig  of monoclonal  anti-V5  antibody  coupled  to  protein  G- 
sepharose and left for 2h on a shaking platform.
The pellets were washed gently 3 times in a buffer composed of 50mM Tris (pH7.5), 0.1 mM 
EGTA and 0.5M NaCl.  The pellets were washed a further 2 times  in the same buffer but 
without NaCl.  The protein was then resuspended  in PBS  and  aliquots  were  incubated  at 
ambient,  5%  and  1%  O2  concentrations.  To  measure  Renilla  luciferase  activity,  the 
immunoprecipitated protein  was  treated  as  described  for  HeLa  cells  transfected  with  the 
mtRLuc-pcDNA3 plasmid.
2.17  Statistical Analysis
Data are expressed as the arithmetic mean ± SEM.  Differences between pairs of variables 
were assessed with the Students’s t test.  Differences between multiple groups of variables 
were  assessed  by  Analysis  of  Variance  (ANOVA)  followed  by  Tukey’s  Multiple 
Comparison post-test.  P < 0.05 was considered to be statistically significant.
853  RESULTS
863.1  Inhibition of Cellular Oxygen Consumption
Mitochondrial respiration is the major component of total cellular O2 consumption (Brown, 
1999;  Piantadosi,  2002).  Manipulation  of the  mitochondrial  ETC,  through  the  use  of 
pharmacological  inhibitors,  would  be  expected  to  prevent  mitochondrial,  and  therefore 
cellular, respiration.  In order to investigate this, RAW264.7 cells were treated with rotenone 
(a complex I inhibitor; Lambert & Brand, 2004), myxothiazol (a complex HI inhibitor; Raha 
et al.,  2000) or sodium azide  (a complex IV  inhibitor;  Petersen,  1977).  In  addition,  NO 
donors  were  administered to  cells  to  examine  the short-  (minutes)  and  long-term  (hours) 
effects of NO on cellular respiration.
3.1.1  Inhibition of Respiration by Pharmacological Inhibitors
Untreated control RAW264.7 cells respired at a constant rate of 13.97 ± 1.02pM  0 2 /min (n = 
5),  which  was  independent  of the  O2  concentration  in  the  range  measured  (Figure  10). 
Repeated additions  of sodium azide  (ImM) resulted  in a dose-dependent inhibition  of O2 
consumption  (Figure  11);  similar  observations  were  obtained  with  rotenone  and 
myxothiazol.  A single bolus treatment with rotenone (500nM), myxothiazol (1 pM) or azide 
(5mM)  completely  inhibited  respiration  (>90%  inhibition;  Figure  12),  confirming  that 
mitochondria  are  indeed  responsible  for  most  of cellular  O2  consumption.  Since  these 
inhibitors act at different complexes of the ETC, respiration  can therefore be inhibited by 
blocking the ETC at various sites.
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Figure 10.  The  0 2   consumption  of  control  RAW264.7  cells.  The  rate  of  0 2  consumption  was 
independent of the 0 2 concentration and was at a constant rate of 13.97pM/min (n = 5).  The tracing was 
obtained from one of five independent experiments.
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Figure 11.  The cumulative inhibition of 0 2   consumption  by  repeated  additions of sodium  azide.
Cells were treated with sequential additions of sodium azide (ImM; indicated by the arrows) and the 
effects upon 0 2 consumption were measured.  Percentage values show the rate of respiration relative to 
the  control  tracing  at the  equivalent  0 2  concentrations.  The tracing was obtained  from  one  of five 
independent experiments.
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Figure 12.  The  inhibition  of Oz  consumption  by  a  bolus  addition  of a  respiratory  inhibitor.  A
single treatment with a respiratory inhibitor (indicated by the arrow) was made and the effects upon 0 2  
consumption  were  measured.  Rotenone  (500nM),  myxothiazol  (lpM)  or  sodium  azide  (5mM) 
completely inhibited (>90% inhibition) cellular 0 2 consumption.
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Figure 13.  The inhibition of respiration by NO.  DEANO (5pM) was added (indicated by arrow) and 
NO was released (up to a maximum concentration of lpM; blue tracing).  Cellular 0 2 consumption (red 
tracing) was inhibited in the presence of NO but recovered after the NO was degraded.  Numerical values 
represent the rates of respiration relative to the control  at equivalent 0 2 concentrations.  The tracings 
were obtained from one of three independent experiments.
893.1.2  Reversible Inhibition of Respiration by NO
Nitric oxide is a reversible inhibitor of complex IV of the ETC, acting in competition with 
O2 (Brown and Cooper, 1994; Cleeter etal., 1994; Schweizer and Richter, 1994).  The short- 
acting NO donor 2,2-diethyl-1-nitroso-oxyhydrazine (DEANO; ti/2 = 2mins; Keefer et al., 
1996)  was  used to  investigate the  short-term  effects  of NO  upon  cellular respiration.  A 
single bolus addition of DEANO (5pM) to RAW264.7 cells at about 75pM O2 resulted in the 
transient release of NO (up to a maximal concentration of 1 pM, as measured using an NO 
electrode)  with  a  concomitant  inhibition  of cellular  respiration  (Figure  13).  This  effect 
disappeared when the NO was completely degraded and respiration recovered to the control 
rate.  The  duration  of the  inhibitory  effect  of NO  appeared  to  be  greater  at  a  lower  O2 
concentration.  However,  the  same  concentration  of DEANO  produced  greater  maximal 
concentrations of NO at lower O2 concentrations, as  detected  by an NO electrode (Figure 
14).
3.1.3  Persistent Inhibition of Respiration Caused by NO
The  long-acting  NO  donor  DETA  (ti/2  =  20hrs;  Keefer  et al.,  1996)  was  used  to  treat 
RAW264.7 cells with NO at a constant concentration for prolonged periods.  DETA (2.5mM) 
released a steady-state concentration of 0.85 ± 0.12pM NO (n = 3), as measured by an NO 
electrode, to  cells  suspended  in  complete  incubation  medium.  This  concentration  of NO 
inhibited  cellular  respiration  (>90%  inhibition  compared  with  untreated  controls)  in  a 
manner  that  was  initially  completely  reversed  by  the  addition  of  the  NO  scavenger 
oxyhaemoglobin (oxyHb; 20pM; Figure 15).
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Figure 14.  The inhibition of respiration by NO at different 0 2  concentrations.  DEANO (5pM) was 
added sequentially (indicated by arrows) and the NO that was released was detected by the NO electrode 
(blue tracing).  The inhibition of respiration (red tracing) exerted by NO increased in duration at lower 
0 2 concentrations.  However, larger quantities of NO were detected at lower 0 2 concentrations, despite 
the  addition of the same amount of DEANO.  The tracings were obtained  from one  of at  least three 
independent experiments.
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Figure 15.  The reversible inhibition of respiration by NO released by DETA.  (a) 0 2 consumption of 
control cells,  (b) 0 2 consumption of cells incubated for  lh with DETA (2.5mM).  The arrow indicates 
the addition of oxyhaemoglobin (20pM) which scavenged the NO.  Percentage values indicate the rate of 
respiration relative to the control.  The tracings were obtained from one of 3 independent experiments.
91After prolonged exposure to NO, the cellular 0 2 consumption became less reversible by the 
addition of oxyHb (Figure 16).  After 2h incubation with DETA (2.5mM), oxyHb could only 
partially  reverse the effects  of NO  and  respiration remained  inhibited  by 20.2%  (13.78  ± 
0.71pM/min  in  controls  to  10.99  ±  1.23pM/min in treated  cells;  n  =  3)  compared to  the 
control rate.  After 4h exposure, however, respiration was significantly inhibited by 63.8% 
(13.94 ± 0.95pM/min in controls compared with 5.05 ± 0.67pM/min in treated cells; n = 3; P 
<  0.01),  even  after  all  the  NO  was  scavenged  by  oxyHb  (Figures  16  and  17).  Thus, 
prolonged  treatment  with  the  NO  donor  DETA  caused  an  inhibition  of respiration  that 
persisted even after removal of NO by oxyHb.
It has  been  reported  that this  persistent  inhibitory  effect  of NO  can  be prevented  by  the 
addition of exogenous antioxidants (Clementi et al.,  1998; Beltran et al., 2000; Orsi et al., 
2000).  Consistent with this, the addition of reduced glutathione ethyl-ester helped to prevent 
this  effect  (Figure  18).  In  the  absence  of glutathione  ethyl-ester,  the  rate  of cellular 
respiration  following  treatment  with  DETA  for  4h  was  persistently  inhibited  by  63.8% 
(Figure  16) compared with  control cells, after the addition  of oxyHb.  In the presence  of 
2.5mM  glutathione  ethyl-ester  the  persistent  inhibition  was  reduced,  to  46.0%  (13.94  ± 
0.95pM/min in the controls to 7.53 ± 0.88pM/min in the treated cells; n = 3; P < 0.05), and 
with  5mM glutathione  ethyl-ester the persistent  inhibition  was  further reduced,  to  27.6% 
(13.94 ± 0.95|iM/min  in the controls  to  10.10 ±  1.62pM/min  in the treated cells;  n  =  3). 
Glutathione ethyl-ester itself did not affect the rate of cellular respiration.  Thus, glutathione 
ethyl-ester  significantly  attenuated  the  persistent  inhibition  of  respiration  caused  by 
prolonged treatment with NO.
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Figure 16.  The persistent inhibition of respiration by NO.  Treated cells were incubated with 2.5mM 
DETA.  Oxyhaemoglobin (oxyHb; 20( jM) was then added to scavenge the NO and the rate of respiration 
was measured.  OxyHb became less able to reverse the inhibition of respiration indicating that NO had 
exerted a persistent effect upon respiration.  * P < 0.05 compared with control,  n = 3.
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Figure 17.  The persistent inhibition  of respiration  caused  by prolonged  exposure to NO.  (a)  0 2
consumption of control cells,  (b) 0 2  consumption of cells incubated with DETA (2.5mM) for 4h.  Arrow 
indicates  the  addition  of oxyhaemoglobin  (20pM).  Numerical  values  represent the  0 2  consumption 
relative to the control.  The tracings were obtained from one of at least 3 independent experiments.
Furthermore, the persistent inhibition of respiration has been attributed to the modification, 
and subsequent inhibition, of complex I as a result of its interactions with NO (Clementi et 
al.,  1998).  In agreement with this,  complex I activity  in RAW264.7  cells  was  found to  be
93significantly  inhibited  by  48.5%  (10.39  ±  0.74nmols/min/mg  in  the  control  to  5.35  ± 
0.71nmols/min/mg in the treated cells; n = 3; P < 0.05) following treatment with DETA for 
4h.  In  the  presence  of glutathione  ethyl-ester  (5mM)  this  inhibition  was  significantly 
reduced,  such  that  the  complex  I  activity  was  only  inhibited  by  20.5%  (11.15  ± 
1.32nmols/min/mg  in  the  glutathione  ethyl-ester-treated  controls  compared  with  8.86  ± 
0.80nmols/min/mg in cells treated with DETA and glutathione ethyl-ester; n = 3; Figure 19). 
The  onset  of decrease  in  complex  I  activity  was  consistent  with  the  appearance  of the 
persistent inhibition of respiration caused by prolonged exposure to NO.
DETA that was completely decomposed, by leaving it for 24h at 37°C, did not release NO, 
as measured by an NO electrode, and had no effect upon the respiration of RAW264.7 cells 
(data not shown).
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Figure 18.  The  effects  of  glutathione  ethylester  (GSH-EE)  on  the  persistent  inhibition  of 
respiration caused by NO.  Cells were incubated with DETA (2.5mM) in the presence or absence of 
GSH-EE  (2.5  or  5mM)  for  the  times  indicated.  Oxyhaemoglobin  (20pM)  was  added  prior  to 
measurement of the rate of respiration.  GSH-EE alone did not affect the rate of respiration compared 
with the controls.  DETA caused a persistent inhibition of respiration after 4h of treatment, an effect that 
was dose-dependently prevented by GSH-EE.  * P < 0.05 compared with control,  n = 3.
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Figure 19.  The effects of DETA on complex I activity in RAW2647 cells.  Cells treated with DETA 
(2.5mM) for 4h showed a significant decrease in complex I activity.  Co-treatment with GSH-EE (5mM) 
prevented this decrease.  GSH-EE itself did not change complex I activities compared with controls.  * P 
< 0.05 compared with control,  n = 3.
953.2  Inhibition of Cellular Respiration in Activated RAW264.7 Cells
In the previously described results, donor compounds were used to investigate the short- and 
long-term effects of NO on cellular O2 consumption.  However, the kinetics and quantities 
of NO  released may not reflect endogenous production.  Furthermore,  certain NO  donors 
release  additional  chemical  species  (Yamamoto  and  Bing,  2000),  such  as  cyanide  from 
sodium  nitroprusside  (Ruan  et  al.,  1999)  and  O2'  from  3-morpholinosydnonimine 
hydrochloride  (Lepore  et  al.,  1999),  which  may  confound  experiments.  In  order  to 
investigate the effects of endogenously-produced NO on cellular respiration, RAW264.7 cells 
were activated to express the iNOS protein.
3.2.1  Activation of RAW264j  Cells Induces iNOS Protein Expression and 
Nitric Oxide Synthesis
RAW264.7 cells were activated with LPS (lOOng/ml) and IFNy (50U/ml).  Activation of the 
cells  resulted  in the time-dependent expression  of iNOS  protein,  as  detected  by Western 
blotting  (Figure 20).  The  protein was  not detected  in  control  cells  but was  significantly 
elevated  4h  after  activation  and  increased  throughout  the  experiment  (up  to  12h)  as 
determined by densitometry (Figure 21).
The concentration of nitrite, a metabolite of NO,  in the medium was measured to indicate 
iNOS protein activity and to quantify the amounts of NO that were produced.  The nitrite 
concentration  was  significantly  increased  6h  after  activation  and  continued  to  rise 
throughout the experiment, up to 178.02 ± 8.90p,M (n = 3) at 24h post-treatment.
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Figure 20.  The time-dependent expression of iNOS in activated RAW264.7 cells.  RAW264.7 cells were 
activated with LPS  (lOOng/ml) and IFNy (50U/ml).  The western blot shows the expression of iNOS 
protein, which increased throughout the experiment (up to  12h).  iNOS was not detected in untreated 
control cells.  Actin was used as a protein loading control.  The Westerns blots shown were obtained 
from one of at three separate experiments.
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Figure 21.  Relative band intensities obtained from densitometry measurements of iNOS Western 
blots from activated RAW2< 4,7 cells.  The expression of the iNOS protein displayed a time-dependent 
increase,  increasing throughout the experiment.  A  significant increase was  initially detected  at 4  hrs 
post-activation.  * P < 0.05 compared with control,  n = 3.
Between  18 and 24h, the rate of increase of nitrite concentration decreased compared with 
that between 6 and  18h (Figure 22).  No nitrite was detected in the medium of control cells 
at any time.
97RAW264.7 cells were also activated in the presence of L-NIO (500pM), an inhibitor of NOS 
activity.  The presence of L-NIO did not significantly affect the expression of iNOS protein 
(Figure 23) but completely prevented the synthesis of NO, as measured by an NO electrode, 
up to 18h and, therefore, the production of nitrite (Figure 24).  L-NIO alone did not induce 
the expression of iNOS protein, neither did it alter nitrite concentrations in the medium.
3.2.2  Reversible  Inhibition  of  Respiration  by  Nitric  Oxide  in  Activated 
RAW264.7 Cells
RAW264.7 cells that were activated with LPS and IFNy for 6h produced NO (over 2p,M), as 
measured  by  an  NO  electrode.  Furthermore,  cellular  respiration  was  found  to  be 
concomitantly inhibited by over 90% (n = 3).  Addition of L-NMMA (ImM) to activated 
cells,  to  inhibit  NOS  activity,  rapidly  inhibited  the  production  of  NO,  resulting  in  a 
decreased  signal  from the NO  electrode.  Following the  prevention  of NO  synthesis,  the 
respiration of activated cells was no longer inhibited and recovered to a rate similar to that 
of the controls.  In comparison, the addition of myxothiazol (lpM) also completely inhibited 
O2 consumption (Figure 25).
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Figure 22.  The increase in the concentration of nitrite in the medium of activated RAW264.7 cells.
Nitrite concentrations in the medium of control cells were unchanged.  Nitrite in the medium of activated 
cells was significantly increased  12h after activation with LPS  (lOOng/ml)  and IFNy (50U/ml).  * P < 
0.05 compared with control,  n > 3.
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Figure 23.  Activation of RAW264.7 cells in the presence of L-NIO does not affect the expression of 
iNOS protein.  Samples from control and treated cells (with LPS + IFNy, L-NIO or a combination of 
both treatments) were collected at 0, 6, 12 and 18h.  The cells were lysed and prepared for Western blot 
analysis.  iNOS  protein  was detected  using  a polyclonal  antibody.  Blots  are representative of at 
least 3 independent experiments.
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Figure 24.  The increase of nitrite in the medium of activated RAW2647 cells can be prevented by L- 
NIO (500pM).  Activated cells significantly increased nitrite concentrations 12 hrs after activation, and 
continued  to  rise  throughout  the  experiment.  Activation  in  the  presence  of  L-NIO  abolished  this 
increase.  L-NIO  treatment alone did not  alter the nitrite  concentrations.  *  P  < 0.05  compared with 
control,  n > 3.
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Figure 25.  Activated  RAW264.7  cells  produced  NO  which  reversibly  inhibited  respiration.  (a)
Control cells did not produce NO.  (b)  Cells activated for 6h produced NO  in sufficient quantities to 
inhibit respiration.  Upon the addition of L-NMMA (500pM), NO synthesis was blocked and respiration 
recovered to control rates.  Myxothiazol (1 pM) completely inhibited 0 2  consumption.  The tracings were 
obtained from one of at least three independent experiments.
100Cells that were activated for 6h in the presence of L-NIO  did not synthesise any NO,  as 
detected  by  an  NO  electrode,  and  respired  at  a  similar  rate  to  the  controls  (14.02  ± 
1.19pM/min for controls and 13.78 ±  l.OlpM/min for cells activated in the presence of L- 
NIO; n = 5).  Addition of L-NMMA to these cells did not change the rate of respiration.
Thus, RAW264.7 cells activated for 6h with LPS and IFNy produced NO in quantities that 
were sufficient to inhibit cellular respiration by over 90%.  This inhibition was sensitive to 
L-NMMA and was prevented when cells were activated in the presence of L-NIO.
3.2.3  Persistent  Inhibition  of  Respiration  Caused  by  Nitric  Oxide  in 
Activated RAW264.7 Cells
After 12h activation, RAW264.7 cells continued to synthesise NO (3pM), as measured by an 
NO electrode and the Griess assay (Figures 22 and 26).  Respiration was also found to be 
inhibited.  In contrast to 6h post-activation, addition of L-NMMA to block NO synthesis did 
not completely reverse the inhibition of respiration, which remained inhibited by two-thirds 
of the control rate (Figure 26).
Previous results showed that the persistent inhibition of respiration caused by NO, derived 
from NO donors, was accompanied by a decrease in complex I activity.  Therefore, complex 
I activity in the activated R A W 2 6 4 .7  cells was also measured.
101Figure 26.  The persistent inhibition of respiration caused by NO in activated  RAWM 4.7 cells.  (a)
Control cells,  (b) Cells activated for 12h produced NO and exhibited an inhibition of respiration.  When 
L-NMMA (500|iM) was added to block NO synthesis, cellular respiration did not return to control rates 
but remained inhibited.  The tracings were obtained from one of at least three independent experiments.
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Figure 27.  Complex I activities of control and activated RAW264.7 cells in the presence and absence 
of I^NIO (500pM).  The complex I activity of control and L-NIO cells remained unchanged throughout 
the experiment.  Complex I activity of activated cells was inhibited by 62% at 12h post-treatment. This 
decrease in complex I activity was prevented by L-NIO.  * P < 0.05 compared with control,  n > 3.Complex I activity in activated cells was unchanged compared with the controls until  12h 
post-treatment,  at  which  time  it  was  significantly  inhibited  by  62%  (9.92  ± 
0.57nmols/min/mg  in controls to  3.77 ±  0.98nmols/min/mg  in treated  cells;  n = 4-6;  P < 
0.05).  This was consistent with the time of onset of the persistent inhibition of respiration. 
The enzyme activity remained significantly inhibited for the duration of the experiment (up 
to  18h;  Figure  27).  In  contrast,  control,  L-NIO-treated control  and  cells  activated  in the 
presence of L-NIO did not exhibit any changes in complex I activity.
When  the  RAW264.7  cells  were  activated  for  12h  in  the  presence  of L-NIO,  so  that  NO 
synthesis  was  completely  prevented,  the  rate  of respiration  was  found  to  be  consistently 
inhibited by 20% (14.27 ± 0.57pM/min in controls to 11.57 ± 0.34pM/min; n = 3; P < 0.05) 
compared to the L-NIO-treated control rate (Figure 28).  This small but significant inhibition 
of respiration was independent of NO, since NOS was completely inhibited and NO could 
not be detected by the NO electrode or by the Griess assay (Figures 24 and 28).
In summary, RAW264.7 cells activated for 12h produced NO and exhibited an inhibition of 
respiration.  This inhibition could not be completely reversed by the addition of L-NMMA, 
which  was  in  contrast to cells  that were  activated for only 6h.  Consistent with previous 
experiments involving DETA, the persistent inhibition of respiration was accompanied by a 
decrease in complex I activity.  Furthermore, when cells were activated in the presence of L- 
NIO, which completely prevented NO synthesis, they
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Figure 28.  NO-independent inhibition of respiration  in activated RAWM7 cells,  (a) Cells treated 
with L-NIO (500|iM) did not produce NO and respired at the same rate as controls,  (b) Cells activated in 
the presence of L-NIO for  12h respired 20% less than the L-NIO-treated control.  The tracings were 
obtained from one of at least three independent experiments.
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Figure 29.  The expression of HO-1 and iNOS in activated RAW26 4.7 cells.  HO-1  was upregulated in 
cells activated in the presence and absence of L-NIO.  In the absence of L-NIO, HO-1  was found to be 
upregulated  12h post-activation whereas it was upregulated after 6h in the presence of the inhibitor.  L- 
NIO did not affect the timecourse of iNOS protein expression.  The Western blots are representative of at 
least 3 independent experiments.
104respired  20%  less  than  the  L-NIO-treated  controls,  indicating  that  an  NO-independent 
inhibition of respiration had occurred.
3.2.4  Haem  Oxygenase-1  Protein  is  Upregulated  in  Activated  RAW26 4j  
Cells
It  has  been  reported  that  activated  cells  upregulate  the  expression  of the  HO-1  enzyme 
(Wiesel etal., 2000; Srisook and Cha, 2004).  This enzyme synthesises CO (Tenhunen et al., 
1969), a molecule that,  like NO, has been shown to inhibit complex IV and subsequently 
block O2 consumption (Petersen, 1977).
In  agreement  with  published  observations,  activated  RAW264.7  cells  did  indeed  strongly 
upregulate HO-1  protein as determined by Western blotting (Figure 29).  The timecourse of 
HO-1  upregulation  was  delayed  compared  with  that  of  iNOS  in  NO-producing  cells. 
Whereas  iNOS  protein  was  upregulated  within  6h  of  cell  activation,  HO-1  was  not 
upregulated until  12h.  However,  in the absence of NO (when  cells  were activated  in the 
presence of L-NIO), HO-1  protein was upregulated earlier and at the same time as  iNOS. 
The timecourse of iNOS upregulation was unaltered regardless of whether NO was present 
or not.  HO-1  protein expression did not significantly change  in control or L-NIO-treated 
cells that were not activated (Figure 29).
Since CO is known to bind to and inhibit complex IV (Petersen,  1977), the activity of this
enzyme was measured in activated cells in the presence and absence of L-NIO.  Complex IV
activity of cells  activated  for  12h was  found to  be significantly  inhibited by 62%  (157 ±
6.03nmols/min/mg in controls compared with 61.22 ± 16.56nmols/min/mg in activated cells;
105n  =  4-5;  P  <  0.05)  compared  with  the  control  (Figure  30).  Similarly,  cells  that  were 
activated for 12h in the presence of L-NIO also displayed significantly reduced complex IV 
activity of a similar magnitude (68% inhibition compared with L-NIO-treated cells;  166.60 
±  12.56nmols/min/mg  in L-NIO-treated controls and  53.09 ±  13.62nmols/min/mg  in cells 
activated in the presence of L-NIO; n = 4-5; P < 0.05).  Control and L-NIO-treated cells did 
not show significant changes in complex IV activity through the duration of the experiment.
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Figure 30.  Complex IV activity of activated RAW2H.7 cells.  Complex IV activity in activated cells 
was decreased in the presence or absence of L-NIO, suggesting an NO-independent cause (n = 4-5).  * P 
< 0.05 compared with control.  ** P < 0.05 compared with L-NIO-treated cells.
1063.3  Inhibition of Respiration by Carbon Monoxide
Inhibition  of respiration by  exogenous  CO has  been reported to  occur in  mitochondria at 
complex IV of the ETC (Alonso et al., 2003).  However, previous work has mostly involved 
the use of the isolated cytochrome c oxidase enzyme (Petersen,  1977).  Here, the effects of 
exogenous  CO  on  the  respiration  of intact HEK293  cells  were  investigated.  These cells 
were used because they could easily be transfected with the HO-1  gene under the control of 
a tetracycline-inducible promoter, and used to  investigate whether endogenously-produced 
CO from HO-1 could also inhibit respiration.
3.3.1  Carbon Monoxide Gas Inhibits Cellular Respiration
Solutions  of CO  gas  were  administered  to  HEK293  cells  at  concentrations  of 5-20pM. 
Cellular  respiration  was  found  to  be  inhibited  in  a  dose-dependent  manner.  At  a 
concentration  of 20pM  CO,  respiration  was  inhibited  by  40%  (18.62  ±  0.74pM/min  in 
controls to 11.63 ± 0.75pM/min, n = 3; P < 0.05) in the range 10-30pM O2 on the respiration 
tracings  (Figure  31 A).  Furthermore,  the  effects  of CO  were  still  evident  30mins  after 
treatment (Figure 3IB).  Thus the effects of CO  were persistent.  From the data obtained, 
Lineweaver-Burk  and  the  derived  secondary  plots  were  made  and  the  K;  of  CO  for 
respiration in HEK293 cells was calculated to be 1  44pM.
The inhibition of respiration by CO that was observed was modest compared to that by NO 
(Figure  31 A).  However,  CO  is  only  able  to  bind  to  and  inhibit  complex  IV  when  the 
enzyme is in the reduced state (Petersen, 1977; Piantadosi, 2002).  The previous
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Figure 31.  Inhibition of cellular respiration by exogenous CO.  (A) Main figure: (i) A tracing of the 
0 2 consumption of control HEK293 cells,  (ii) The 0 2 consumption of cells treated with 20pM CO.  (iii) 
A tracing showing the comparative effects of 5pM DEANO (addition indicated by arrow).  The rate of 
respiration recovers after the NO is degraded.  Insert:  The  slopes obtained from the Lineweaver-Burk 
plot  were  plotted  against  [CO]  (secondary  plot).  The  Ki  of CO  on  respiration  was  calculated  by 
interpolation  to  the  x-axis  and  was  1.44pM.  Tracings  are  representative  of at  least  3  independent 
experiments.  (B) The rates of respiration of HEK293 cells were measured 0, 10, 20 and 30mins after the 
addition of 20pM CO (n = 3).  *P<0.05 compared with controls.
experiments were carried out at ambient O2 concentrations, a condition that maintains the 
ETC in an oxidised state.  Thus, to shift complex IV into a more reduced state, experiments 
were also performed under hypoxic (1% O2) conditions.
108Incubation of HEK293  cells  with  CO under hypoxic conditions  for  lOmins  increased  the 
inhibitory effect of the gas.  Using 20pM CO, respiration was  inhibited by 75% (19.14 ± 
0.82pM/min  in  controls  to  4.92  ±  0.52pM/min,  n  =  3;  P  <  0.05),  compared  with  40% 
inhibition observed at ambient O2 concentrations (Figure 32).  The Kj of CO for respiration 
in  HEK293  cells  incubated  under  hypoxic  conditions  was  calculated  to  be  0.35pM. 
Respiration in control HEK293 cells was not affected by hypoxic incubation.
3.3.2  Haem  Oxygenase-1-Derived  Carbon  Monoxide  Inhibits  Cellular 
Respiration
The  human  HO-1  gene,  under  the  control  of  a  tetracycline-inducible  promotor,  was 
transfected into HEK293  cells (HEK293-HO-1).  After induction of the gene for 24h with 
tetracycline  (lpg/ml) a significant  expression  of HO-1  protein  was  observed  (Figure 33). 
All following experiments were performed under these conditions.
Bilirubin is an indirect product of HO-1  activity and was used as an indicator of functional 
HO-1  enzyme.  As  shown  in  Figure  34,  induced  HEK293-HO-1  cells  had  1.42pM  of 
bilirubin in the medium compared with 0.97pM in the non-induced control.  This indicated 
that the HO-1 protein induced was functional.
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Figure 32.  Inhibition  of  cellular  respiration  by  exogenous  CO  in  HEK293  cells  incubated  in 
hypoxia (1% 0 2).  (i) the 0 2 consumption of control cells incubated in hypoxia,  (ii) the 0 2 consumption 
of cells treated with 20 pM CO under ambient 0 2 concentrations,  (iii) the 0 2 consumption of cells treated 
with 20pM CO  in hypoxia.  No difference was observed between untreated  control  cells kept under 
ambient 0 2 concentrations and those  incubated  in hypoxia.  The K;  of CO  for cells  in hypoxia was 
calculated to be 0.35pM.  The tracings were obtained from one of at least 3 independent experiments.
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Figure 33.  The  expression  of HO-1  following  induction  of HEK293-HO-1  cells.  HEK293-HO-1 
cells were  treated  with  tetracycline  (lpg/ml)  for  24h  and HO-1  protein  expression  was  detected  by 
Western blotting.
Following incubation under ambient O2 conditions, the induced HEK293-HO-1  cells  were 
found to respire less than the non-induced control cells.  Within the range of 10-30pM O2 on 
the respiration traces, the respiration of the induced HEK293-HO-1  cells was  inhibited by 
12% (18.57 ± 1.06pM/min in controls to 16.33 ± 0.87pM/min, n = 3; P < 0.05; Figure 35).
110Following  induction  under  hypoxic  conditions  (1%  O2)  the  induced  cells  were  found  to 
respire at 30% of the control rate - an inhibition of 70% (18.35 ± 0.74 in controls to 5.24 ± 
0.67pM/min, n = 3; P < 0.05; Figure 35).  The greater inhibition after hypoxic incubation is 
consistent  with  the  pattern  of  observations  from  previous  experiments  that  involved 
exogenous CO.  Hypoxic incubation did not affect the induction of HO-1  protein in these 
cells,  as  determined  by  Western  blotting,  nor  the  activity  of  the  enzyme,  since  the 
concentration of bilirubin  in the medium of cells  induced at  1%  O2  was  not significantly 
different from that of the cells induced under ambient O2 concentrations (Figure 36).
3.3.3  Haem  Oxygenase-1-Derived  Carbon  Monoxide  Inhibits  Cellular 
Respiration in Activated RAW264.7 Cells
RAW2647 cells  activated  for  12h upregulated the expression  of HO-1  protein  (Figure 29). 
This enzyme from activated cells  was found to produce significantly greater quantities  of 
bilirubin compared with the controls, both  in the presence and absence  of L-NIO  (Figure 
37), consistent with the upregulation of the active enzyme.  In the absence of L-NIO 3 .48 ± 
0.19pM  (n  =  6)  bilirubin  was  detected  in  the  incubation  medium  of  activated  cells, 
compared with 1.34 ± 0.07pM (n = 3) in the untreated control.  In the presence of L-NIO,
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Figure 34.  Induced HEK293-HO-1  cells produce more bilirubin.  The concentration of bilirubin in 
the medium of induced HEK293-HO-1  cells was  increased to  1.42pM compared with 0.97pM in the 
uninduced.  This indicates that active HO-1  protein was expressed,  n = 3.  # P < 0.05 compared with 
control.
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Figure 35.  Induced HEK293-HO-1 cells exhibit a decreased rate of respiration.  The respiration of 
induced HEK293-HO-1 cells incubated under ambient 0 2  concentrations (ii) and hypoxic conditions (iii) 
was decreased compared with uninduced cells (i).  The tracings were obtained  from one of at least 3 
independent experiments.
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Figure 36.  The expression and activity of HO-1 protein is not altered by incubation under hypoxic 
conditions.  (A)  Western blot  analysis of cell extracts from induced  and uninduced  HEK-HO-1  cells 
incubated under ambient (21% 0 2) or hypoxic (1% 0 2) conditions.  (B) Bilirubin concentration in the 
medium of induced cells was unchanged by hypoxic  incubation,  n  =  3.  *  P  < 0.05  compared with 
control at 21% 0 2.  ** P < 0.05 compared with control at 1  % 0 2.
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Figure 37.  The concentration of bilirubin in the medium of activated RAW2 < 4 .7 cells was greater 
than the controls both in the presence and absence of the NOS inhibitor L-NIO.  This is consistent 
with the upregulation  of HO-1  protein,  n  =  3-6.  *  P  <  0.05  compared  with  control.  **  P  <  0.05 
compared with  L-NIO-treated non-activated  cells.  # P  <  0.05  compared  with  activated  cells  in  the 
absence of L-NIO.
although more bilirubin was detected (2.76 ± 0.18pM, n = 4) in the medium of activated 
cells  compared with the L-NIO-treated control cells  (1.25  ± 0.13pM,  n = 3),  the  increase 
caused by activation was less than that observed in the absence of L-NIO.  Thus, activated 
cells  that  were  allowed  to  synthesise  NO  produced  significantly  more  bilirubin  than 
activated cells that could not do so.
In cells activated for  12h cellular O2 consumption was almost totally inhibited, but in the 
presence  of  L-NIO,  which  completely  blocked  NO  synthesis,  the  inhibition  of  O2 
consumption was reduced to 20% (11.57 ± 0.34pM/min compared with 14.27 ± 0.57pM/min 
in  controls,  n  =  3-4,  P  <  0.05).  When  the  cells  were  activated  at  1%  O2,  this  NO- 
independent inhibitory effect was  increased to 60% (4.92 ± 0.40pM/min in activated cells 
compared with 11.33 ± 0.42pM/min in non-activated controls, n = 3-4, P < 0.05; Figure 38). 
In addition, complex IV activity was decreased to 53.09 ± 13.62nmol/min/mg from 166.60 ±1 2 . 5 6   p r o t e i n   ( n   =   4 ,   P   <   0 . 0 5 )   f o l l o w i n g   c e l l   a c t i v a t i o n   f o r   1 2 h   in   t h e   p r e s e n c e   o f  L - N I O  
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Figure 38.  The respiration of activated cells.  The respiration of cells  activated for  12h was almost 
completely  inhibited.  Activated  cells  that  did  not  synthesise  NO  still  exhibited  an  inhibition  of 
respiration that was increased by hypoxic incubation.  n = 3-5.  ** P < 0.05 compared with control.  *P< 
0.05 compared with respective L-NIO-treated controls.  $ P < 0.05 compared with L-NIO-treated cells 
maintained at 21% 0 2.  # P < 0.05 compared with cells activated in the presence of L-NIO at 21% 0 2.
1 . 8 5 |i M / m i n   ( 6 1 %   i n h i b i t i o n ;   n   =   3 ;   P   <   0 . 0 5 )   a f t e r   2 4 h .   C o m p l e x   I V   a c t i v i t y   w a s   a l s o  
s i g n i f i c a n t l y   d e c r e a s e d   f o l l o w i n g   h y p o x i c   i n c u b a t i o n   f o r   1 2 h   f r o m   1 5 7 . 1 5   ±   6 . 0 4   t o   8 8 . 2 5   ±
1154.31  nmol/min/mg  protein  (n  =  3-4;  P  < 0.05;  Figure 39C).  This  is  consistent with  CO 
binding to,  and  inhibiting,  complex IV.  The  upregulation  of HO-1  and the  inhibition  of 
respiration  observed  following  hypoxic  incubation  was  not  observed  in  the  non-induced 
control HEK293-HO-1 cells (Figures 32 and 36A).
Another interesting observation was that RAW264.7 cells activated under hypoxic conditions 
produced less NO compared with cells activated at ambient O2 concentrations (Figure 40). 
NO production, as determined by the Griess assay and an NO electrode, was  significantly 
reduced at 1% (lOpM) O2.  Nitrite, a metabolite of NO, concentration was reduced by 85% 
at 1% O2 compared with ambient conditions after 24h (178.02 ± 8.90pM to 27.15 ± 2.60pM, 
P <  0.05).  The  concentration  of NO  in  the  incubation  medium,  measured  using  an  NO 
electrode,  was  0.3 pM at  lOpM O2 compared  with 2.3 pM at  lOOpM.  This  decrease  is  in 
agreement with the observed 85% reduction in the amount of nitrite measured.  In addition, 
the Km  of iNOS for O2 was found to be between 20 and 30pM in our cells (Figure 40B).
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F ig u r e  3 9 .  H y p o x ic   in c u b a tio n   o f R A W 264.7  c e lls  in d u c e d   th e   e x p re s s io n   o f  H O -1   p r o te in   a n d   w a s  
a c c o m p a n ie d   b y  a  d e c re a s e  in   th e   r a te  o f c e llu la r  r e s p ir a tio n   a n d   c o m p le x   IV   a c tiv ity .  (A) Hypoxia 
induced the expression of HO-1  protein both in controls and L -N IO  treated cells.  (B ) Respiration in cells 
incubated at 1% 0 2 for 12h (ii) or 24h (iii) was inhibited by 41% and 61% respectively.  (C) Complex IV 
activity  of cells  incubated  in  hypoxia  for  12h  was  decreased  compared  with  those  incubated  under 
ambient 0 2 concentrations.  * P < 0.05 compared with control,  (n = 3-4).
117This decrease in NO synthesis in hypoxia was not due to a change in the expression of iNOS 
(Figure 41 A) and was more likely to be due to inhibition of enzyme activity resulting from a 
reduction  in  the  availability  of the  substrate  O2.  In  contrast,  however,  the  amount  of 
bilirubin produced by cells activated in the presence of L-NIO was unaffected by hypoxia, 
indicating  that  HO-1  is  unaffected  by  low  O2.  This  is  consistent  with  the  previous 
observations obtained from the induced HEK293-HO-1  cells (Figure 36).  However, in the 
absence  of  L-NIO  more  bilirubin  was  produced  by  activated  cells  at  ambient  O2 
concentrations than  in hypoxia (Figure 41B),  suggesting a link between the production of 
NO and the activity of HO-1.
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Figure 40.  The synthesis of NO is inhibited by hypoxia.  (A) Production of NO in activated R.AW2647 
cells was inhibited by 85% under hypoxia, as determined by the concentration of its metabolite nitrite. 
(B) NO  decreased  from  a concentration of 2.3pM  at  lOOpM 0 2  to 0.3 pM  at  lOpM 0 2  (indicated by 
dashed arrows).  The Km  for steady-state NO concentrations at different 0 2 tensions in RAW264 7 cells 
was between 20-30pM (indicated by the dotted line),  n = 3.
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Figure 41.  The expression of iNOS and the synthesis of bilirubin  under hypoxic and  ambient 0 2  
concentrations in activated RAW2M  7 cells.  (A) The induction of iNOS was unaltered by activation of 
cells in hypoxia.  (B) Bilirubin concentrations in the medium of cells after  12h (n = 3-6).  * P  <   0.05 
compared with control at 1% 0 2.  ** P <  0.05  compared with L-NIO-treated cells at  1% 0 2.  # P <  0.05 
compared with control at 21% 0 2.  ## P  <  0.05  compared with L-NIO-treated cells at 21% 0 2.  $ P <  
0.05 compared with activated cells at 1% 0 2.
1203.4  Modulation  of  the  Hypoxic  Induction  of  Hypoxia  Inducible 
Factor 1a Protein Stability by Mitochondria
Since  mitochondria  are  responsible  for  90%  of a  cell’s  O2  consumption,  it  would  be 
expected  that  inhibition  of  this  usage  would  result  in  changes  to  the  availability  of 
intracellular  O2,  particularly  under hypoxic  conditions  when  O2  may  be  limiting  for  0 2 - 
dependent reactions.  To  investigate this, HIFla, a protein whose stability is  known to be 
02-dependent  (Ivan  et al.,  2001;  Jaakkola  et al.,  2001),  was  investigated  in  relation  to 
mitochondrial respiratory activity.
3.4.1  Inhibition of Respiration  Prevents the Hypoxic  Induction  of HIFla 
Protein and its Transcriptional Activity
HEK293 cells incubated in hypoxia (1% O2) for 3h stabilised HIFla protein.  The presence 
of  the  respiratory  inhibitors  myxothiazol  (lpM),  sodium  azide  (5mM),  antimycin  A 
(lpg/ml) or rotenone (500nM) completely prevented this stabilisation (Figure 42A).  Thus, 
inhibition  of the ETC  at various sites produces the  same destabilising  effect  on hypoxia- 
induced HIFla protein.  A similar phenomenon was also observed in a variety of other cell 
lines, including Hep3B, 143B and HeLa cells, treated with myxothiazol (lpM; Figure 42B). 
Thus, this HIFla destabilising effect is not a cell-specific phenomenon.
HIFla-dependent  reporter  gene  activity  was  also  increased  (11-fold)  following  hypoxic 
treatment for 5h.  This too was abolished by the addition of the mitochondrial inhibitors,
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Figure 42.  Inhibition  of  mitochondrial  respiration  prevents  hypoxia-dependent  HIFla 
stabilisation.  (A) HEK293  cells were incubated at  1% 0 2 for 3h in the presence of the mitochondrial 
respiratory  inhibitors  myxothiazol  (lpM),  sodium  azide  (5mM),  antimycin  A  (lpg/ml)  and  rotenone 
(0.5(iM), as indicated.  HIFla was detected by Western blotting.  (B) Four different human cell types 
(HEK293, Hep3B hepatocellular carcinoma cells,  143B osteosarcoma cells and HeLa cervix carcinoma 
cells) were incubated at 1% 0 2  in the presence or absence of lpM myxothiazol.  HIFla was detected by 
Western blotting.
indicating that the  transcriptional  effects  of HDFla  are  correlated  with  the  stability  of the 
protein  and  are  similarly  affected  by  respiratory  inhibition  at  various  sites  of the  ETC 
(Figure 43A).  In addition, HIFla protein stabilisation and HIFla-dependent reporter gene 
activity were significantly inhibited by the addition of exogenous NO, released from DETA 
(10-100pM), in a dose-dependent manner (Figure 43B).A
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Figure 43.  Inhibition  of  mitochondrial  respiration  prevents  hypoxia-dependent  HIFla 
stabilisation.  (A) HIFla-dependent  gene reporter  activity  was  measured  at 21%  and  1%  0 2 in  the 
presence of inhibitors, as indicated.  (B) HEK293 cells were incubated at 1% 0 2 for 3h (HIFla protein) 
or 5h (HIF1 a reporter activity) in the absence or presence of the NO donor DETA.
1233.4.2  Destabilisation  of  HIFla  is  Due  to  Increased  Degradation  of the 
Protein
The  increased  stability  of HIFla  protein  in  hypoxia  could  be  due  to  an  alteration  in  its 
degradation, its synthesis, or both.  To investigate this, the proteasome inhibitor, MG-132, 
and the protein synthesis inhibitor, cycloheximide, were used.
In the presence of MG-132, ubiquitinated HIFla protein could be detected at 21% O2.  This 
is  consistent with the inhibition of proteasomal degradation.  Under hypoxia,  both HIFla 
protein and its ubiquitinated form were detected in the presence and absence of MG-132. 
Inhibition of mitochondrial respiration by myxothiazol prevented the stabilisation of HIFla 
in  hypoxia.  In  the  presence  of both  MG-132  and  myxothiazol,  however,  ubiquitinated 
HIFla was still present whereas HIFla protein was not.  These results are consistent with 
myxothiazol stimulating the targeting for degradation of HIFla protein (Figure 44  A).
When  HIFla  protein  was  allowed  to  accumulate  under  hypoxia  and  then  myxothiazol 
added, the protein was completely degraded within 45min.  The addition of cycloheximide 
to  prevent  protein  synthesis,  however,  resulted  in  a  much  slower  rate  of  HIFla 
disappearance, which was still visible after 90min (Figure 44B).  The difference in the rates 
of HIFla protein  destabilisation  indicates  that myxothiazol  does  not act by inhibiting the 
synthesis of the transcription factor.
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Figure 44.  Inhibition of mitochondrial  respiration  in  HEK293 cells  prevents HIFla  stabilisation 
by promoting HIFla degradation.  (A) High-molecular-weight ubiquitinated HIFla protein  species 
were detected by Western blotting with a monoclonal antibody after incubation of cells at 21% or 1% 0 2  
for 3h in the presence or absence of lpM myxothiazol  and 25pM MG-132,  as indicated.  (B) HIFla 
protein was allowed to  accumulate to levels shown  at time zero by incubating cells for 4h  at  1  % 0 2. 
Cells were then treated with  lpM myxothiazol or  17.5pM cycloheximide.  Cell lysates were obtained 
after 20, 45 and 90mins and analysed by Western blotting.
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Figure 4S.  Inhibition of mitochondrial respiration in HEK293 cells prevents HIFla stabilisation in 
a ROS-independent manner.  Cells were incubated  at  1%  0 2 for 3  hours in  the presence (A) or the 
absence  (B)  of  lpM  myxothiazol.  The  antioxidants  ascorbate  (Asc.,  2.5mM),  glutathione  ethyl  ester 
(GSH,  5  mM),  and  N-acetylcysteine  (NAC,  5mM)  were  included  as  indicated.  HIFla  protein  was 
determined by Western blotting.
3.4.3  Reactive 0 2   Species  are  not  Involved  in  the  Regulation  of HIFla 
Protein Stability
Reactive  O2  species  have  been  implicated  in  the  regulation  of  hypoxia-induced  HIFla 
protein stability.  If ROS destabilised HIFla protein (Huang et al.,  1996; Salceda and Caro, 
1997) then antioxidants should attenuate this effect.  However, in the presence of ascorbate, 
glutathione ethyl-ester or N-acetylcysteine, myxothiazol still destabilised HIFla in hypoxia 
(Figure 45 A).  In addition,  the generation of ROS  by mitochondria varies according to the 
site of the ETC  which  is  inhibited  (Waypa et al.,  2002;  Chen et al.,  2003).  However,  all 
inhibitors of the ETC destabilised the hypoxia-induced HIFla protein, regardless of the site
126of inhibition (Figure 42A).  Thus, under the experimental conditions and in the cells used 
ROS did not appear to be involved in the regulation of HIFla protein stability.
ROS have also been implicated in the stabilisation of HIFla protein (Chandel et al.,  1998; 
Chandel et al., 2000a).  In this situation, antioxidants should attenuate the accumulation of 
the protein.  Again, antioxidants did not have an effect on the hypoxia-induced stabilisation 
of the protein (Figure 45B).  These results demonstrate that ROS  are not involved  in the 
stabilisation or destabilisation of hypoxia-induced HIFla protein.
3.4.4  Inhibition  of  Respiration  in  Hypoxia  Increases  Intracellular  0 2  
Availability
In  order  to  investigate  if  the  inhibition  of  mitochondrial  respiration  increases  the 
intracellular  O2  concentration,  Renilla  luciferase,  whose  activity  is  dependent  on  its 
substrates coelenterazine (added in excess) and O2 only, was targeted to the mitochondria of 
HeLa  cells.  The  activity  of this  enzyme  was  found  to  be  reduced  by  decreasing  O2 
concentrations.  At 5% O2 the activity of the immunoprecipitated enzyme was significantly 
inhibited by 25% compared with control enzyme at 21% O2.  Further inhibition (80%) was 
observed at 1% O2 (Figure 46A).  In intact cells the activity was significantly inhibited by 
(55%)  at  5%  O2  and  was  further inhibited  (by  85%)  at  1%  O2  (Figure 46B).  Thus,  the 
activity of the Renilla luciferase enzyme was correlated with the O2 concentrations.
Cells containing Renilla luciferase and incubated at 1% O2 were then treated with NO, from
DETA (l-100pM), to inhibit respiration and the activity of the enzyme was measured.  The
activity of the luciferase was negligible in hypoxia in the absence of DETA.  However, it
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Figure 46.  (^-dependence  of  Renilla  luciferase  activity.  (A)  Immunoprecipitated  mitochondrial 
Renilla luciferase activity is 0 2-dependent in vitro.  (B) Mitochondrial Renilla luciferase transfected into 
HeLa cells demonstrates 0 2-dependence.  (n = 3; single asterisk indicates P < 0.01; double asterisks, P < 
0.05; means ± SEM).
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Figure 47.  HeLa cells expressing mitochondrially targeted Renilla luciferase were incubated with 
increasing  concentrations  of DETA  (0  to  lOOpM)  in  a  hypoxia  chamber  at  1%  0 2.  After  the 
addition of the substrate coelenterazine (5|ig/ml), luminescence was determined in the hypoxia chamber. 
NO caused a concentration-dependent increase in luciferase activity.  When re-equilibrated to 21% 0 2, 
no effect of DETA-NO on luciferase activity was observed.
1293.4.5  Inhibition  of  Mitochondrial  Respiration  Prevents  Cell  Density- 
Dependent HIFla Stabilisation
H3F la-dependent gene reporter activity was  measured  in HEK293  cells  that were  seeded 
onto  cell  culture  plates  at  different densities  in the  presence  or  absence  of myxothiazol 
(lpM) under ambient O2 concentrations.  As shown in Figure 48, increasing the density at 
which cells were maintained resulted in higher reporter activity, such that a 7-fold increase 
was observed at the highest density (1.40 x 106cells/cm2) compared with that of the lowest 
(0.12 x 106cells/cm2).  However, in the presence of myxothiazol, the cell density-dependent 
gene reporter activity was abolished.
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Figure 48.  Inhibition  of  mitochondrial  respiration  prevents  cell  density-dependent  HIFla 
stabilisation.  HIFla-dependent  gene reporter  activity  was measured  in  cells  that were  seeded  onto 
culture plates at different densities in the presence or absence of myxothiazol (lpM) under ambient 0 2  
concentrations.
1304  DISCUSSION
1314.1  Pharmacological Inhibition of Cellular Oxygen Consumption
Mitochondria are responsible for approximately 90% of a cell’s  O2 consumption (Brown, 
1999; Piantadosi,  2002).  Thus,  inhibition  of the ETC would be expected to significantly 
reduce cellular O2 utilisation.  In the present study, this  was  investigated by treatment of 
RAW264.7  cells  with  rotenone  (a  complex  I  inhibitor;  Lambert  and  Brand,  2004), 
myxothiazol  (a complex HI  inhibitor; Raha et al.,  2000)  or sodium  azide  (a  complex IV 
inhibitor; Petersen, 1977).
Control RAW264.7 cells respired at a constant of rate of 13.97pM (Vmin, between 200pM 
and ~10pM O2,  when suspended  in incubation  medium at a concentration  of 107cells/ml. 
Respiration  was  completely  inhibited  (>90%  reduction)  by  treatment  with  rotenone 
(500nM),  myxothiazol  (lpM)  or  sodium  azide  (5mM).  This  effect  of the  inhibitors  is 
consistent  with  reports  that  mitochondria  are  responsible  for the  majority  of cellular  O2 
consumption (Brown,  1999; Piantadosi, 2002).  Also, the inhibitors, which act at different 
complexes,  illustrate that respiration  can  be  inhibited  by  blockade  of the  ETC  at various 
locations and not just at the site of O2 metabolism (i.e. complex IV).  These observations are 
in agreement with a number of studies that show similar inhibitions with the mitochondrial 
inhibitors used (Boveris and Chance, 1973; Chen etal., 2003; Hollis etal., 2003).
1324.2  Inhibition of Respiration by Treatment with Nitric Oxide
In addition to the pharmacological inhibitors used, cells were also treated with exogenous 
NO,  derived from NO  donor compounds,  for short (minutes)  or long (hours)  durations  of 
time and their respiration was measured.  NO is a potent inhibitor of complex IV, acting in a 
manner that is reversible and in competition with O2 (Brown and Cooper,  1994; Cleeter et 
al, 1994; Schweizer and Richter, 1994).
4.2.1  Reversible  Inhibition  of  Respiration  by  Acute  Treatment of Cells 
with Nitric Oxide
The  NO  donor DEANO  has  a  half-life  of 2mins  (Keefer  et al.,  1996)  and  was  used  to 
investigate the acute effects of NO on the respiration of RAW264.7 cells.  The concentration 
of DEANO that was  used  (5pM) produced a  maximum  of lpM NO,  which  is  similar to 
concentrations of NO that have been measured to be produced by activated macrophages 
(Brown et al.,  1998).  This quantity of NO completely inhibited the O2 consumption of the 
cells,  an  observation  that  has  similarly  been  reported  by  others  (Brown  et  al.,  1998). 
Furthermore, when the NO was broken down, respiration returned back to the control rate. 
Thus, the inhibition of respiration was reversible.
The mechanism by which NO was broken down may be due to a combination of different 
phenomena.  It has been proposed that NO can be metabolised by complex IV of the ETC to 
produce N02- (Torres et al.,  1995; Cooper et al.,  1997).  However,  it is not clear whether 
this is a major mechanism.  NO also reacts rapidly with O2’ at a near-diffusion-limited rate 
(6.7 x 109 NrV1; Huie and Padmaja, 1993).  It has been shown that the addition of SOD, to
133metabolise O2’ into H2O2, noticeably increases the amount of NO (by approximately lOOnM) 
detected  in  submitochondrial  particles  treated  with  DETA  (Riobo  et  al.,  2001).  This 
experiment shows that O2’, which is likely to be produced by the ETC, may be a significant 
mechanism by which NO is metabolised.  In addition, NO can react directly with 0 2.  The 
rate at which this reaction occurs is thought to be slow at physiological concentrations  of 
NO  (lOnM to  lpM)  such that the half life of NO,  due to the  reaction  with  O2,  has been 
estimated  to  range  from  9  to  900mins  depending  on  its  concentration  (Beckman  et al., 
1996).  However,  it  has  been  reported  that  this  reaction  is  increased  by  300-fold  in 
hydrophobic membranes (Liu etal.,  1998).  This could make the reaction between NO and 
O2  a  significant  pathway  for  the  metabolism  of NO  and  could  explain  why,  at  lower 
concentrations of O2,  more NO was  found to  be released from the  same concentration  of 
DEANO.  Recently,  it  was  reported  that  NO  could  be  consumed  by  cells  via  a  lipid 
peroxidation pathway (Keynes et al., 2005).  This mechanism was also  02-dependent and 
required the presence of ascorbate.
Another interesting observation was that NO could inhibit respiration even when the 02:NO 
ratio  was  high.  For  example,  at  80pM  O2,  lpM  NO  was  found  to  be  sufficient  to 
completely inhibit respiration.  This is a phenomenon that has been commented on by others 
(Boveris etal., 2000; Brown, 2001) and is interesting because both O2 and NO have similar 
association rate constants for frilly reduced complex IV (108  N f V 1  and 0.4-1.0 x 108  I V r V 1  
respectively;  Babcock  and  Wikstrom,  1992;  Blackmore  et al.,  1991),  yet  NO  is  able  to 
completely  inhibit  the  enzyme  even  when  there  is  a  relative  abundance  of  O2.  A 
mechanistic explanation for this has been proposed in which NO initially binds onto the Cub 
site of the binuclear centre giving it a kinetic advantage over O2 for the binding to the haem
134a3  (Torres  et al.,  1995).  Alternatively,  it has  been  suggested  that  NO  is  able  to  inhibit 
complex  IV  potently  because  it  is  capable  of binding  to  the  partially  reduced  enzyme, 
whereas O2 can only bind onto the fully reduced enzyme (Antunes et al., 2004).  Thus, NO 
is  able to bind to,  and  inhibit,  complex IV before the  enzyme becomes  available  for O2. 
Nevertheless, the precise explanation for the high potency of NO as an inhibitor of complex 
IV, even at high O2 concentrations, remains to be clearly defined.
4.2.2  Persistent  Inhibition  of  Respiration  Caused  by  Prolonged 
Treatment with NO
Although NO reversibly inhibited cellular respiration upon acute exposure, it also caused a 
persistent inhibition of respiration  in cells following prolonged treatment.  The NO donor 
DETA (2.5mM) has a half-life of 20hrs (Keefer et al.,  1996)  and released NO at a steady 
concentration  of 0.85|iM,  which  was  sufficient to  inhibit  cellular  respiration  completely. 
Under this  treatment,  R A W 2 6 4 .7   cells  were  exposed  to  NO  for  up  to  4hrs.  Initially,  the 
inhibition  of respiration  could  be  reversed  back to  the  control  rate  upon  the  addition  of 
oxyHb (20pM), which rapidly scavenged the NO released.  After 2h of exposure, however, 
respiration could not be completely reversed by oxyHb and remained inhibited by 20.2%. 
After  4h  of exposure  to  NO,  respiration  was  persistently  inhibited  by  63.8%  after  the 
addition of oxyHb.  Similar patterns of events have been reported by others in a variety of 
cells (Clementi etal., 1998; Beltran etal., 2000; Orsi et al., 2000).
The  explanation  for these  observations  was  proposed to  be  due to  the  S-nitrosylation  of
complex I of the ETC.  In agreement with these studies, the addition of glutathione ethyl-
ester  reversed  the  persistent  effects  caused  by  NO,  a  characteristic  indicative  of  S-
135nitrosylation (Bauer et al.,  1995).  In addition, complex I activity decreased concomitantly 
with the onset of the persistent inhibition of respiration, which could also be prevented by 
glutathione ethyl-ester.  Recently, it was shown that there is a direct correlation between the 
rate of cellular O2 consumption and complex I activity in activated macrophages (Frost et 
al., 2005).
In contrast, others have reported an irreversible inhibition of respiration that was attributed 
to nitration by ONOO' (Bolanos et al.,  1994; Riobo et al., 2001; Carreras et al., 2004).  In 
these studies the addition of SOD could prevent irreversible inhibition, by metabolising O2’ 
and preventing the formation of ONOO’,  and they therefore  concluded that the  causative 
agent was ONOO'.  Although ONOO’ is capable of both nitrosylation and nitration (Radi et 
al., 2002), the work done by Clementi et al suggests that ONOO' is not involved.  This  is 
because scavengers of ONOO’ did not prevent the persistent inhibition and no ROS  were 
detected, arguing against the presence of ONOO'.  Furthermore, cold light and glutathione 
ethyl-ester could reverse this inhibition, a phenomenon that is consistent with S-nitrosylation 
(Bauer  et  al.,  1995).  Interestingly,  it  has  been  reported  that  both  S-nitrosylation  and 
nitration of complex I may occur in concert in activated macrophages (Frost et al., 2005).  It 
was shown that an early NO-dependent inhibition of complex I activity could be prevented 
by the addition of reduced glutathione ethyl-ester, indicating S-nitrosylation.  The ability of 
glutathione ethyl-ester to block this  inhibition diminished with time and was coupled with 
the appearance of nitrotyrosine residues, indicating protein nitration.  Thus, the manner by 
which complex I is inhibited by NO exhibits temporal changes.  In the RAW264.7 cells used 
in my experiments, it is possible that continued exposure to NO would result in the nitration 
of complex I, and the inability of glutathione ethyl-ester to prevent this inhibition.The significance of the S-nitrosylation and inhibition of complex I remains to be clarified.  It 
has been demonstrated that inhibition of complex I has  detrimental effects  upon cells and 
induces  apoptosis  (Seaton  et al.,  1998;  Barrientos  and  Moraes,  1999).  In  addition,  S- 
nitrosylation  may  be  involved  in  pathophysiological  situations  that  occur  when  cells  are 
under  oxidative  stress  (Beltran  et  al.,  2000).  In  contrast,  it  has  been  suggested  that 
nitrosylating  reactions  may  be  involved  in  cellular  signalling  events  (Stamler,  1994). 
Furthermore, S-nitrosylation has been proposed to modulate the activity of GAPDH (Padgett 
and Whorton, 1995), creatine kinase (Wolosker et al.  1996) and the ryanodine receptor (Xu 
et  al.,  1997).  Thus,  whether  S-nitrosylation  of  complex  I  is  a  physiological  or 
pathophysiological phenomenon remains to be determined.
1374.3  Inhibition of Cellular Respiration in Activated RAW264.7 Cells
In  previous  experiments,  exogenous  NO,  through  the  use  of NO  donors,  was  used  to 
investigate the effects of NO on cellular respiration.  However, these donors may not release 
NO in the quantities, nor with the kinetics, that reflects endogenous production.  In addition, 
some  NO  donors  may  release  other  chemical  species  which  may  confound  experiments 
(Yamamoto and Bing, 2000).  Sodium nitroprusside, for example, releases the cyanide anion 
(Ruan et al.,  1999), which is also a known inhibitor of complex IV.  As a result, exogenous 
NO  donors  may  not  be  suitable  for  experiments  on  cellular  respiration.  Cells  can  be 
stimulated, however, to synthesise NO for prolonged periods, such that the acute and long­
term effects of endogenous NO on cellular respiration can be investigated.
Although murine macrophage cells  can be stimulated to  express  iNOS  with  relative ease, 
stimulation of human macrophages is comparatively difficult.  The poor reproducibility or 
minimal  response  of human  macrophages,  even  following  treatment  with  a  variety  of 
cytokines, has led to the suggestion that iNOS induction in these cells may not be important 
in humans.  Nevertheless, iNOS has been shown to be present in other human phagocytic 
cells, such as neutrophils, and an increase in nitrite and nitrate is observed during infections 
(Harvey, 2000).
4.3.1  Reversible Inhibition of Respiration in Activated RAW264.7 Cells
RAW264.7  cells  activated  with  LPS  and  IFNy  expressed  iNOS  and  produced  NO  in 
micromolar quantities  (see also Brown et al.,  1998  and  Connelly et al.,  2003).  6h post­
activation, the cells produced NO  in sufficient quantities to completely inhibit respiration.
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cells.  This  inhibition  was  completely  abolished  upon  addition  of the  NOS  inhibitor  L- 
NMMA and the  cells  respired  at a  similar rate  to  the  non-activated  controls.  Thus,  the 
inhibition of respiration was attributed to NO synthesised from iNOS and was reversible at 
this 6h timepoint.  In addition, cells activated in the presence of L-NIO, which inhibited NO 
synthesis throughout the experiment, respired at a similar rate to the control.  This further 
supports the observation that NO was responsible for the inhibition of respiration.
The upregulation of iNOS  was found to be significant 4h after activation of the RAW264.7 
cells.  However,  nitrite  concentrations  were  not  significantly  elevated  until  12h  post­
activation.  This discrepancy can be attributed to the relative insensitivity of the Griess assay 
that was used to measure nitrite concentrations.  It has been reported that the Griess assay is 
able to detect nitrite concentrations with a sensitivity limit of 0.1-1 .OpM (Nagano, 1999).  At 
4h post-activation, it is possible that the nitrite, produced from the metabolism of NO, was 
below this detection limit.  At 6h post-activation, however, enough nitrite had accumulated 
to allow the detection of a significant elevation in the medium.  In contrast, the NO electrode 
has a detection limit of InM (Zhang and Broderick, 2000) and is, therefore, more sensitive 
in the detection of NO.
Although the nitrite  concentrations  were  measured,  nitrate,  the  other stable  metabolite  of 
NO,  was  not.  The  total  nitrate  and  nitrite  concentrations  would  have  provided  a  better 
indication  of  NO  synthesis  and  possibly  have  resolved  the  discrepancy  between  the 
expression of iNOS and the detected increase in NO synthesis indicated by the Griess assay.
139The  rate  of  increase  in  nitrite  concentrations  was  linear  between  6  and  18h  post  cell 
activation.  Between  18  and  24h,  however,  the  rate  decreased.  This  could  be  due  to  a 
decrease in the availability of L-arginine in the medium.  L-arginine is a substrate for NO 
synthesis  and  is  metabolised  as  NO  is  produced.  As  the  concentration  of L-arginine 
decreases it is reasonable to expect that the rate of NO, and therefore nitrite, synthesis would 
similarly decrease.  In addition, the enzyme arginase is upregulated following cell activation 
(Chicoine et al, 2004).  This enzyme has a higher activity in metabolising L-arginine than 
does NOS and it has been shown that inhibition of arginase can significantly increase the 
synthesis of NO by NOS (Chang et al,  1998).  Furthermore, it has been reported that 90% 
of L-arginine is consumed by arginase,  whereas the remaining  10%  is  consumed by NOS 
(Hrabak etal,  1994).  This would help to explain why extracellular L-arginine is required 
for iNOS activity in activated cells.
Nevertheless,  reduction in the availability of other necessary cofactors  or cosubstrates  for 
NOS activity can also not be discounted.  Alternatively, the activity of iNOS  could have 
become inhibited by NO.  It has been shown that the activity of iNOS  is decreased in the 
presence of NO (Assreuy etal, 1993).  The mechanism by which this occurs was described 
as being due to the formation of a haem-NO complex within the enzyme.  This would have 
the  subsequent  effect  of  increasing  the  Km   of  the  enzyme  for  O2  and  inhibiting  the 
consumption of NADPH and the production of citrulline,  all  indicative of an  inhibition of 
the enzyme’s activity.
Cells that were activated in the presence of the NOS inhibitor L-NIO did not synthesise NO, 
as determined by the Griess assay, up to the 18h timepoint.  Between 18 and 24h, however,
140an  increase  in  the  concentration  of  nitrite  in  the  medium  of  the  cells  was  detected, 
suggesting  iNOS  activity.  For  this  reason,  experiments  measuring  respiration  in  cells 
activated in the presence of L-NIO were measured at the 12h timepoint when no NO was 
detected by either the Griess assay or by the NO electrode.
4.3.2  Persistent Inhibition of Respiration in Activated RAW24.7 Cells
At  12h after cell activation, the inhibition of respiration could not be completely reversed 
upon blockade  of NO  synthesis  by the addition  of L-NMMA,  indicating  that cellular  O2 
consumption had been inhibited persistently.  Since the onset of persistent inhibition was 
accompanied  by  a  decrease  in  complex  I  activity  in  cells  treated  with  exogenous  NO, 
complex I activity was also measured in the activated RAW264.7 cells.  In agreement with 
previous  experiments  using  exogenous  NO,  complex  I  activity  of  activated  cells  was 
significantly decreased (by 62%).  Since the activity of complex I in cells activated in the 
presence of L-NIO did not change, this effect can be attributed to NO or one of its derived 
species.
As  discussed previously,  the mechanism  by which the complex was  inhibited  is  likely to 
involve S-nitrosylation.  This is  supported by the effects  of glutathione ethyl-ester,  which 
prevented the inhibition of complex I.  However, it remains possible that complex I may also 
be nitrated at a later stage, as has been proposed (Frost etal., 2005)
It was also observed that cells activated for 12h in the presence of L-NIO respired less than
L-NIO-treated control cells  by  20%.  This  inhibition was  not due to  NO  because no NO
synthesis was detected by the NO electrode or by the Griess assay.  Also, this inhibition was
141not due to  an  inhibition  of complex I,  since the activity  of this  enzyme  was  not altered. 
However,  measurement of complex IV activity showed that  it  was  significantly  inhibited 
suggesting an alternative mechanism.
4.3.3  Expression of Haem Oxygenase-1  in Activated RAW264j  Cells
Complex  IV  activity  of RAW264.7  cells  activated  in  the  presence  of L-NIO  for  12h  was 
inhibited by 68%.  It has been reported that activated cells are induced to express the HO-1 
protein (Wiesel et al., 2000;  Srisook and  Cha,  2004) and that exogenously-added CO can 
bind to  and  inhibit complex IV as the isolated enzyme  (Petersen,  1977)  or in  intact cells 
(Alonso et al., 2003).  Therefore, HO-1  protein expression was investigated in my activated 
RAW264.7 cells and, in agreement with other reports (Wiesel et al., 2000;  Srisook and Cha, 
2004),  was  found to  be  elevated.  Thus,  it was  hypothesised  that HO-1-derived  CO  was 
responsible for the NO-independent inhibition of complex IV and respiration in the activated 
cells.  However,  it  has  not  previously  been  thoroughly  investigated  whether  or  not 
exogenous  or  endogenous  CO,  produced  by  HO  enzymes,  is  able  to  inhibit  cellular 
respiration.
Although both complex I and IV activities were measured, it would have been beneficial to 
have  measured  the  activities  of complex  II  and  HI.  This  would  have  provided  a  more 
complete picture of the changes  in  the  mitochondrial  ETC  and  would  have  shown  if the 
changes  observed  were  specific  for  the  complexes  investigated.  This  is  particularly 
important  since  contrasting  effects  upon  the  different  complexes  have  been  reported 
(Bolanos etal., 1994; Beltran etal., 2000).
1424.4  Inhibition of Cellular Respiration by Carbon Monoxide
4.4.1  Carbon Monoxide Gas Inhibits Cellular Respiration
When HEK293 cells were treated with solutions of CO gas, the rate of O2 consumption was 
found to be reduced in a dose-dependent manner.  Similar observations have been reported 
by others (Alonso et al.,  2003).  Furthermore, this  inhibition was greater when  cells were 
incubated under hypoxic conditions.  From my data I have calculated that the K * of CO for 
complex IV was  1.44pM following incubation under ambient O2 concentrations.  This was 
decreased to 0.35pM at  1%  O2,  indicating that complex  IV has  a greater affinity  for CO 
under hypoxic conditions.  These values are similar to those previously reported for purified 
complex IV and for complex IV contained in proteoliposomes (Petersen,  1977; Hansen and 
Nicholls, 1978).  They indicate that CO is a much less potent inhibitor of complex IV than is 
NO, which has a reported I C 5 0  of 60nM at 30pM O2 (Brown and Cooper,  1994) and a Ki of 
27nM (Koivisto et al.,  1997).  In addition to the different affinities of complex IV for NO 
and CO, the redox state of cytochrome a3 could also determine the potency of CO to inhibit 
the enzyme.  CO is only able to bind to complex IV when cytochrome a3 is reduced (in the 
ferrous form), whereas NO is capable of binding to complex IV when cytochrome a3 is in 
the reduced or oxidised form.  Under low O2 concentrations the ETC is in a more reduced 
state  (Duranteau  et  al.,  1998;  Palacios-Callender  et  al.,  2004),  which  may  favour  the 
inhibition of complex IV by CO.  This may explain, at least in part, the increased potency of 
CO as an inhibitor of complex IV in hypoxia.
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least 30mins.  However, the rate of dissociation (‘k0ff’) of CO from complex IV has been 
reported to be 2 x 10‘Y 1  (Erecinska and Wilson, 1980), a value that is similar to that of NO 
(1-13  x  10‘V 1;  Antunes et al., 2004),  and the  inhibition due to  NO  is  rapidly  reversible. 
Thus, there is a discrepancy between the duration of the observed respiratory inhibition by 
CO, and its reported kinetics with complex IV.  Nevertheless,  others have shown that the 
inhibition  of complex  IV  activity  by  CO  persists  for  several  days  (Miro  et  al.,  1998). 
Similarly, the binding of CO to haemoglobin, another haem protein, has been reported to last 
for over 6 hrs.  In addition, the rate of dissociation of CO from myoglobin has been reported 
to be significantly slower than that of O2 and NO (Gibson et al., 1986).
In contrast, however, the rates of association (‘kon’) of both O2 and NO have been reported 
to be greater than that of CO (1 x K^NfV1  for O2, 0.4-1.0 x lC^M^s'1  for NO and 8 x 104M‘ 
Y 1   for CO; Babcock and Wikstrom,  1992; Blackmore et al.,  1991; Erecinska and Wilson, 
1980).  Thus, the association of 0 2  or NO to  complex IV  is approximately 3-4  orders  of 
magnitude greater than that for CO, suggesting that O2 and NO are more dynamic than CO 
for the binding to the enzyme.
4.4.2  Haem  Oxygenase-1-Derived  Carbon  Monoxide  Inhibits  Cellular 
Respiration
HEK293 cells were transfected with the human HO-1 gene and expression was controlled by
a  tetracycline-dependent  promoter.  Induction  of  the  protein  following  treatment  with
tetracycline was verified by Western blotting and the enzyme activity was indicated by an
increase in bilirubin concentration in the cellular medium.
144Induced  HEK293-HO-1  cells  were  able  to  produce  CO  in  sufficient  quantities  to  inhibit 
cellular respiration.  This was accompanied by an inhibition of complex IV activity which is 
consistent with  CO  binding to,  and  inhibiting,  the  enzyme.  As  with  exogenous  CO,  the 
inhibition of respiration was also increased by incubation at 1% O2.  Since HO-1  is an 02- 
dependent enzyme (Tenhunen et al.,  1969), the effect of lowering the O2 tension to 1% on 
the enzyme’s activity was investigated.  We discovered that there was no change in HO-1 
activity,  as  assessed by the accumulation of bilirubin.  The Km   of HO-1  for O2 has  been 
reported  to  be  12pM  (Piantadosi,  2002)  and  in  our  system  we  observed  no  significant 
change in enzyme activity by lowering the O2 concentration to 1% (lOpM).  In addition, the 
expression of the enzyme in these cells was unchanged by incubation of the cells at different 
O2  concentrations.  Thus,  the  increased  inhibition  of respiration  observed  under hypoxic 
conditions was likely to be due to an increased binding of CO to complex IV and not due to 
a change in the expression or activity of HO-1.
4.4.3  Activated  RAW264.7  Cells  Synthesise  Bilirubin  and  Exhibit  an 
Inhibition of Respiration
RAW264.7  cells  activated  in  both  the  presence  and  absence  of L-NIO  upregulated  the
expression  of  HO-1  protein  and  produced  significantly  greater  quantities  of  bilirubin
compared with the  controls,  as  measured by the accumulation  of bilirubin  in the  cellular
medium.  This  indicates  that the  HO-1  protein  was  active  and  producing  CO,  since  the
enzyme synthesises bilirubin and CO  in stoichiometric quantities  (Tenhunen et al.,  1969).
In addition, activated cells that were allowed to produce NO (i.e. cells that were activated in
the  absence  of L-NIO)  synthesised  significantly  more  bilirubin  than  cells  that  could  not
145produce  NO.  This  was  unexpected  because  NO  has  been  reported  to  be  capable  of 
inhibiting HO enzymes (Ding et al.,  1999).  Since NO is a known inducer of HO-1  protein 
(Foresti et al.,  1997; Bouton and Demple, 2000; Srisook and Cha, 2004) it is possible that 
NO  induced  a  higher  expression  of  the  enzyme  resulting  in  a  greater  total  activity. 
However,  the  upregulation  of HO-1  was  found to  be  delayed  (till  12h)  in  the  presence 
compared  with the absence  of NO,  when the  protein  was  upregulated  6h post-activation. 
The  explanation  for  an  apparent  greater  HO-1  activity  in  the  presence  of NO  is  as  yet 
unclear and remains to be investigated.
As discussed previously, the induction of HO-1  was hypothesised to be responsible for the 
NO-independent  inhibition  of respiration  in  activated  RAW264.7  cells.  Consistent  with 
previous  experiments  involving exogenous  or endogenous  CO,  the hypoxic  incubation  of 
cells  significantly increased  (to  60%) this  inhibition,  providing  further  evidence that  CO 
may  be  involved  in  the  inhibition  of cellular  O2  consumption.  In  addition,  complex IV 
activity  was  inhibited  by  66%,  and  this  was  likely  to  have  contributed  directly  to  the 
decreased O2 consumption.  Again, these observations are in agreement with the hypothesis 
that CO is responsible for the inhibition of respiration observed.
4.4.4  Reduction  of NO,  but not CO,  Synthesis  by  Hypoxia  in  Activated 
RAW264.7 Cells
When RAW264.7  cells  were  activated  under ambient conditions  in the absence  of L-NIO, 
nitrite, a metabolite of NO, accumulated in the culture medium.  The concentration of NO, 
measured by an NO electrode, produced by the cells was approximately 3pM at 12h post­
activation.  Under hypoxic conditions the nitrite produced was 6.5-fold less, suggesting that
146O2 was limiting for NO synthesis.  These results are consistent with previous reports which 
show that iNOS activity is affected by the availability of O2.  The Km  of iNOS in cells for O2 
has been shown to be  137pM (McCormick et al., 2000).  In contrast,  it has been reported 
that the Km  of the purified  iNOS protein for O2  is  much  lower,  at 6pM (Rengasamy and 
Johns,  1996).  In our cells, however, we obtain a value of between 20-30pM for the Km  of 
iNOS for O2.  This difference from the value reported by McCormick et al.  may be due to 
the  maintenance  of our  cells  in  biological  stirrer  bottles,  which  could  provide  a  more 
homogeneous  O2  concentration  throughout the  medium  than  in  culture plates.  It  is  also 
greater than the value reported by Rengasamy and Johns.  However, their system involved 
the use of the purified enzyme with the addition of exogenous substrates and cofactors.  This 
may not reflect the availability of the constituents for NO synthesis within a cell.
In  addition,  HO-1  activity  was  found  to  be  unaffected  by  hypoxic  incubation  in  the 
HEK293-HO-1  cells.  A similar observation was seen in the RAW264.7 cells activated in the 
presence of L-NIO.  This  would suggest that at low O2 tensions  CO, produced by HO-1, 
might be more capable of inhibiting mitochondrial  respiration whereas the effects  of NO, 
due to the inactivation of iNOS, might be less significant.
However, cells that were activated in the absence of L-NIO did exhibit a difference in HO-1 
activity depending on the O2 concentration, as indicated by the accumulation of bilirubin in 
the medium of cells.  Under ambient O2 concentrations, 35% more bilirubin was produced 
by  activated  cells  compared  with  cells  activated  at  1%  O2.  Since  HO-1  activity  is 
independent  of the  O2 concentration,  as  previously  shown,  the  difference  in  the bilirubin 
concentrations  is possibly due to the presence of NO.  As  described previously,  a greater
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absence.  Similarly,  under  hypoxic  conditions,  where  less  NO  is  being  produced,  less 
bilimbin is synthesised.
4.4.5  Hypoxia Induces Haem Oxygenase-1  which is accompanied  by an 
Inhibition of Respiration
Hypoxic  incubation  alone  induced  the  expression  of HO-1  protein  in RAW264.7  cells,  an 
observation that has also been reported by others (Morita et al., 1995).  The induction of the 
enzyme was accompanied by a decrease in the rate of respiration.  This phenomenon was 
not observed  in the non-induced HEK293-HO-1  cells,  which  did not upregulate HO-1  in 
response  to  hypoxia.  In  addition,  complex  IV  activity  was  measured  in  RAW264.7  cells 
incubated in hypoxia for  12h and was found to be decreased by 44% compared with non- 
hypoxic  controls.  This  is  consistent  with  our  hypothesis  that  CO  inhibits  respiration, 
particularly  under  low  O2  concentrations,  through  inhibition  of complex  IV.  Previous 
reports  have  similarly  described  a  decrease  in  complex  IV  activity  caused  by  hypoxia 
(Chandel etal., 1996).  It was hypothesised that this may be due to an allosteric alteration to 
the conformation of complex IV caused by the absence of O2 (Chandel et al.,  1996), such 
that  the  enzyme  was  modified.  However,  this  does  not  explain  the  unchanged  rate  of 
respiration in the non-induced HEK293-HO-1 cells following hypoxic incubation.
1484.5  Modulation  of  the  Hypoxic  Induction  of  Hypoxia  Inducible 
Factor 1a Protein Stability by Mitochondria
Previous observations have shown that the inhibition of the mitochondrial ETC results in the 
inhibition  of cellular respiration,  demonstrating that mitochondria  are  responsible  for the 
vast majority of a cell’s O2 consumption.  However, there are other 02-dependent processes 
within a cell, which may compete with mitochondria for the common substrate.  When O2 is 
plentiful, enough is available for these other processes to occur.  When O2 becomes limiting, 
however, non-mitochondrial 0 2 -requiring processes may become inhibited because complex 
IV preferentially consumes the available O2 due to  its  low Km  (high affinity;  Gnaiger and 
Kuznetsov, 2002; Cooper et al., 2003) for O2.  If respiration is inhibited, however, then the 
O2 would be expected to become available for other processes.  The effect of the inhibition 
of respiration  under  hypoxic  conditions  was  therefore  investigated  with  respect  to  the 
stability of HIFla,  a protein whose degradation  is  known to be  an  0 2 -dependent process 
(Ivan et al., 2001; Jaakkola et al., 2001).
4.5.1  Inhibition  of  Respiration  Prevents  the  Hypoxic  Induction  of 
Hypoxia  Inducible  Factor  1a  Protein  and  its  Transcriptional 
Activity
HEK293  cells  incubated  in  hypoxia  (1%  O2)  for  3h  stabilised  the  HIFla  protein,  as
determined  by Western blotting.  This  was  similar to  the  observations  reported  by  other
groups (Berra et al., 2003; Mateo et al., 2003;  Appelhoff et al., 2004).  This stabilisation
was prevented when the cells  were  incubated  in the presence of the respiratory inhibitors
rotenone, myxothiazol, antimycin A, sodium azide or NO.  Therefore, inhibition of the ETC
149at complex I, El or IV prevented the hypoxic stabilisation  of HIFla.  These observations 
have  also  been  previously  reported  by  others  (Mateo  et  al.,  2003).  Furthermore,  the 
transcriptional activity of HIFla was similarly prevented by respiratory inhibition, which is 
consistent  with  the  destabilisation  of  HIFla  protein.  Thus,  active  (02-consuming) 
mitochondria are required for HIFla protein stabilisation and its subsequent transcriptional 
activity,  whereas  inactivated mitochondria  prevents  the transcription  factor’s  stabilisation 
and activity.  In contrast, it has been reported that active mitochondria are not required for 
HIFla stabilisation (Srinivas et al.,  2001).  However,  in these  experiments, 0.5% O2 was 
used for the hypoxia treatment.  This low O2 concentration may have been too low for even 
the 0 2 -dependent prolyl hydroxylases to function, resulting in the inhibition of degradation 
and subsequent stabilisation of HIFla.
Contrasting effects  of NO  on the stabilisation of HEFla have been reported.  In  fact both 
stabilisation (Sandau etal., 2000; Sumbayev etal., 2003) and destabilisation (Sogawa et al., 
1998;  Huang et al.,  1999)  of the protein  has  been  described.  These  studies  often  use  a 
variety of NO  donors  which release NO  at a range  of concentrations  (which  were  rarely 
measured), and which may release other interfering species.  Thus, it is difficult to reconcile 
the reported effects of NO with the effects upon HIFla protein stability.  Recently, however, 
it has  been  shown that NO  has  a biphasic  effect  upon  HIFla  stability.  Using  cells  that 
produced  controlled concentrations of NO  it was  demonstrated that at low concentrations 
(<400nM)  NO  inhibited  the  hypoxia-induced  stabilisation  of  HIFla,  whereas  at  high 
concentrations (>lpM) NO stabilised HIFla even under non-hypoxic conditions (Mateo et 
al., 2003).  It was concluded that the destabilising effect of NO on HIFla protein stability
150was due to its inhibitory effect upon the ETC, whereas the stabilising effect was due to an as 
yet undetermined non-mitochondrial phenomenon.
4.5.2  Destabilisation of Hypoxia Inducible Factor 1a is due to Increased 
Degradation of the Protein
The  destabilisation  of HIFla  protein  could  be  due  to  an  increase  in  its  degradation,  a 
decrease  in  synthesis,  or  a  combination  of both.  The  results  obtained  indicate  that  the 
inhibition  of mitochondrial  respiration  stimulates the  degradation  of HIFla protein,  since 
myxothiazol increased the rate at which HIFla disappeared compared with cycloheximide, 
which inhibited protein synthesis (Figure 44).  The mechanism by which HIFla is degraded 
involves the prolyl hydroxylation of the protein, interaction with pVHL, ubiquitination and 
then subsequent degradation by the 26S proteasomes (Giaccia et ah, 2003; Semenza, 2003). 
It has been reported that this pathway is regulated by the initial prolyl hydroxylation of the 
protein,  a reaction  that  is  regulated  by the  availability  of O2.  These  prolyl  hydroxylase 
enzymes have been shown to have a high Km  (low affinity) for O2, making them good O2 
sensors  (Hirsila et al.,  2003).  Therefore,  at  low  O2  concentrations  they  are  likely to  be 
inactivated  as  a  result  of  their  low  affinity  for  the  substrate,  resulting  in  decreased 
degradation  and  subsequent  stabilisation of HIFla.  If O2  was  made  available again,  the 
prolyl hydroxylases could be reactivated, initiating the targeting for degradation of HIFla. 
Thus, the stimulation of degradation of HIFla protein by myxothiazol is consistent with the 
idea that the inhibition of respiration increases the availability of intracellular O2.
1514.5.3  Inhibition  of  Mitochondrial  Respiration  in  Hypoxia  Increases  the 
Intracellular 0 2 Availability
The activity of the enzyme Renilla luciferase requires only O2 and coelenterazine.  When 
coelenterazine  was  available  in  excess,  the  enzyme’s  activity  was  found  to  be  directly 
related  to  the  concentration  of  O2  both  in  the  immunoprecipitated  enzyme  and  when 
transfected into HeLa cells.  Thus, the activity of the luciferase could be used as a monitor of 
intracellular O2 concentrations.  When respiration was inhibited by NO in cells containing 
the  luciferase,  the  enzyme’s  activity  was  significantly  increased,  as  determined  by  an 
increase  in  luminescence.  This  indicates  that there  was  an  increase  in the availability  of 
intracellular O2.  This increase in O2 could reactivate the prolyl hydroxylase enzymes, which 
were previously inhibited,  explaining how the  inhibition  of respiration destabilises HIFla 
protein  by  stimulating  its  degradation.  A  similar  mechanism  of O2  diversion  has  been 
reported  in  firefly  flashing  experiments  whereby  NO  increased  the  bioluminescence  of 
fireflies by inhibiting respiration and diverting O2 towards the peroxisomes (Trimmer et al., 
2001).  When cells  were treated  with  NO  under ambient  O2 concentrations,  however,  no 
change in luciferase activity was detected.  This shows that NO  does not interact directly 
with the luciferase enzyme and that under ambient conditions, O2 was not limited.
In support of this mechanism, HEK293 cells incubated at higher densities exhibited greater 
HIFla-dependent gene reporter activity.  Cells at a higher density would consume more O2 
from their environment causing local hypoxia and stabilisation of HIFla.  The presence of 
myxothiazol, however, inhibited mitochondrial respiration, preventing O2 consumption and 
hypoxia.  This was mirrored by the abolition of the cell density-dependent activation of the
152gene  reporter  activity.  In  addition,  cells  lacking  a  functional  mitochondrial  ETC  only 
stabilise HIFla at lower O2 concentrations (Mateo etal., 2003).
4.5.4  The Destabilisation of HIFla does not Involve Reactive 0 2 Species
Reactive  O2  species  have  been  proposed to  be  responsible  for the  stabilisation  of HIFla 
(Chandel et al., 2000a; Agani et al., 2000).  In this model, it was suggested that the increase 
in mitochondrial ROS production occurred under hypoxia as a result of decreased complex 
IV  activity  (Duranteau  et  al.,  1998)  and  this  signalled  for  HIFla  protein  stabilisation. 
However, in the HEK293 cells used, a variety of antioxidants (ascorbate, glutathione ethyl- 
ester  and  N-acetylcysteine)  did  not  have  an  effect  upon  hypoxia-induced  HIFla  protein 
stabilisation.  In contrast, ROS, produced by NADPH oxidase, have been claimed to be the 
signal for the stabilisation of HIFla.  Under hypoxic conditions, the activity of this enzyme 
was  proposed  to  decrease  (due  to  a  fall  in  available  O2),  resulting  in  the  decreased 
production  of  ROS  and  providing  the  signal  for  HIFla  protein  stabilisation.  Again, 
antioxidants  did not have an  effect on  either the  stabilisation  or destabilisation  of HIFla 
protein, suggesting that ROS were unlikely to be involved in the regulation of HIFla in the 
HEK293 cells used.
Recently  evidence  has  been  presented  whereby  inactivation  of the  Rieske  iron-sulphur
protein in complex HI of the ETC prevented the formation of mitochondrial ROS in hypoxia
(Brunelle  et al.,  2005).  This  disruption  blocked  the  stabilisation  of HIFla  by  hypoxia,
indicating that mitochondrially-derived ROS are involved in signalling for the stabilisation
of the protein.  Furthermore, cells from p38a* ‘, MKK3  "  or M KK6mice failed to stabilise
HIFla in response to hypoxia (Emerling etal., 2005).  Reintroduction of p38a restored this
153ability.  In  addition,  the  overexpression  of  glutathione  peroxidase  I,  an  enzyme  that 
metabolises H2O2 into water, abolished the hypoxic activation of the p38 MAPK pathway 
indicating  that  H2O2  was  responsible  for  conveying  the  stabilisation  of HIFla  via  this 
mechanism.  Thus,  these  reports  provide  evidence  that  support  the  role  of ROS  in  the 
modulation of HIFla protein stability.
1545  GENERAL CONCLUSION
NO  is  known  to  inhibit  complex  IV  of the  mitochondrial  ETC  rapidly  and  reversibly, 
preventing  O2  consumption  by  mitochondria.  After  prolonged  exposure,  however, 
mitochondrial respiration can become persistently inhibited.  Although much is known about 
the effects of exogenous NO on the ETC, relatively little work has been done to demonstrate 
whether endogenous NO can exert similar effects.  Thus, the initial objective of my work 
was  to  investigate  the  role  of NO  in  the  respiratory  changes  that  occur  in  macrophages 
during inflammatory activation by LPS and IFNy.
Following  cell  activation,  it  was  found  that  the  expression  of  iNOS  was  upregulated, 
resulting  in  the  synthesis  of micromolar  quantities  of NO.  This  NO  initially  inhibited 
cellular respiration in a reversible manner, with the rate of O2 consumption reverting to that 
of the control when NO synthesis was blocked with L-NMMA.  The reversible inhibition 
was  a  consequence  of NO  acting  at  complex  IV  of the  mitochondrial  ETC.  Following 
prolonged  exposure  to  endogenous  NO,  a  phase  of persistent  respiratory  inhibition  was 
observed.  This could not be reversed by blocking the synthesis of NO and was associated 
with a decrease in the activity of complex I.  However, this phenomenon could be prevented 
by  the  addition  of  glutathione  ethyl-ester,  indicating  that  it  was  probably  due  to  S- 
nitrosylation of the enzyme.
In addition, exogenous CO is also known to inhibit complex IV, and HO-1, an enzyme that 
synthesises  this  gas,  was  found  to  be  upregulated  in  activated  cells.  Therefore,  the 
possibility that CO contributes to the respiratory inhibition was investigated.
155It  was  discovered  that  endogenous  CO,  produced  by  HEK293  cells  transfected  with  an 
inducible HO-1  gene, inhibited respiration, albeit mildly.  However, this effect was found to 
be greatly amplified at low O2 concentrations.  In addition,  it was  observed that activated 
macrophages  exhibited  a significant mitochondrial  defect under hypoxic  conditions,  even 
when the generation of NO is inhibited.  The results obtained suggest that this is due to CO, 
released by HO-1, acting at complex IV.  Furthermore, it was observed that HO-1  retained 
its  activity  at  low O2 concentrations,  whereas  iNOS  activity  was  greatly  reduced.  Thus, 
mitochondrial  dysfunction,  which  occurs  in  the  hypoxic  environment  often  found  at 
inflammatory sites, may be a consequence of CO rather than NO.
The consequence of inhibition of mitochondrial activity under these low O2 concentrations 
was investigated.  It was found that the inhibition of cellular respiration in hypoxia resulted 
in the redistribution of intracellular O2 from mitochondrial consumption, as measured by an 
increase  in  activity  of the  Renilla  luciferase  enzyme.  The  subsequent  increase  in  the 
availability of O2 reactivated the prolyl  hydroxylase enzymes,  resulting  in the decrease  in 
stability of hypoxia-induced HIFla protein, creating a situation in which the cells might fail 
to register hypoxia.  The consequences of this effect are unclear at present, and merit further 
investigation.
1566  FUTURE WORK
Although  the  inhibition  of cellular  respiration  by  NO  has  been  abundantly  studied,  the 
inhibition by CO has been given less attention.  It is well known that CO can bind to, and 
inhibit the activity of, isolated complex IV, but only recently has work been reported on the 
effects upon cellular respiration (Alonso et al., 2003).  However, in these experiments, cells 
were incubated in a CO gas/air mixture where the concentration of CO was in the region of 
several  hundred  ppm  and  it  is  unclear  whether  such  quantities  of  CO  are  produced 
endogenously  to  affect  O2  consumption.  The  results  presented  in  this  thesis  provide 
evidence that endogenous CO may indeed inhibit cellular respiration.  However, definitive 
demonstration that this  occurs through the action of CO  on complex IV  remains  lacking. 
Thus,  further  studies  investigating  this  phenomenon  should  address  this  issue,  possibly 
through  the  use  of spectroscopic  tools  to  show  shifts  in  the  absorption  spectra  of the 
complex IV cytochromes due to the binding of CO.
If  endogenous  CO  does  indeed  inhibit  respiration  through  complex  IV,  it  would  be 
interesting  to  investigate  the  consequences  of this  effect  under  hypoxic  conditions.  As 
shown  in  this  thesis,  inhibition  of respiration  in  hypoxia  results  in  the  redistribution  of 
intracellular O2.  Evidence is provided  suggesting that endogenous  CO  rather,  rather than 
endogenous NO, may perform this role:
•  the inhibitory effect of CO is enhanced at lower O2 concentrations,
•  CO  synthesis,  as  indicated  by  HO-1  expression  and  bilirubin  synthesis,  is 
increased in hypoxia, and
•  HO-1 activity is not affected at 1% O2, whereas iNOS activity is greatly reduced.
157In  addition to  the effects  upon  prolyl  hydroxylase activity and HIFla protein  stability,  it 
would be interesting to  investigate the manner in  which other  0 2 -dependent enzymes  are 
affected by the redistribution of O2.  One such enzyme is  iNOS.  The concept that HO-1- 
derived  CO  could  stimulate  the  synthesis  of  NO  by  increasing  intracellular  O2 
concentrations is an intriguing possibility.
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